https://pharmadispatch.com/news/the-genesis-of-the-policy-that-continues-to-shape-pbs-discussion 2019-01-17T16:00:01+11:00 https://pharmadispatch.com/news/bms-to-acquire-celgene 2019-01-04T18:06:01+11:00 https://pharmadispatch.com/news/the-australian-at-the-centre-of-takedas-deal-for-shire 2019-01-10T20:00:01+11:00 https://pharmadispatch.com/news/pfizer-makes-its-cbd-move 2019-01-14T16:00:01+11:00 https://pharmadispatch.com/news/nps-medicinewise-facing-robust-evaluation 2019-01-14T16:00:01+11:00 https://pharmadispatch.com/news/new-report-confirms-exaggerated-spend-on-new-medicines 2019-01-14T16:00:01+11:00 https://pharmadispatch.com/news/where-does-the-government-spend-its-investment-in-the-pbs 2019-01-14T16:00:01+11:00 https://pharmadispatch.com/news/all-eyes-on-dhl-ahead-of-cso-application-cut-off 2019-01-14T16:00:01+11:00 https://pharmadispatch.com/news/new-report-highlights-the-demise-of-f2 2019-01-15T16:00:01+11:00 https://pharmadispatch.com/news/where-does-the-money-come-from-now 2019-01-15T16:00:01+11:00 https://pharmadispatch.com/news/pfizer-adopts-agile-working 2019-01-15T16:00:01+11:00 https://pharmadispatch.com/news/information-forums-on-pbs-fee-hike 2019-01-15T16:00:01+11:00 https://pharmadispatch.com/news/push-to-end-the-lung-cancer-stigma-as-government-announced-new-l 2019-01-21T16:00:01+11:00 https://pharmadispatch.com/news/fundraising-underway-in-the-race-for-pharmacup2019 2019-01-16T16:00:01+11:00 https://pharmadispatch.com/news/transition-of-6cpa-program-administration-underway 2019-01-16T16:00:01+11:00 https://pharmadispatch.com/news/new-drug-discovery-institute-for-melbourne 2019-01-16T16:00:01+11:00 https://pharmadispatch.com/news/mtpconnect-support-for-industry-back-digital-health-accelerator 2019-01-16T16:00:01+11:00 https://pharmadispatch.com/news/takeda-rings-the-bell-in-new-york 2019-01-17T16:00:01+11:00 https://pharmadispatch.com/news/novo-nordisks-michala-fischer-hansen-returning-to-denmark 2019-01-17T16:00:01+11:00 https://pharmadispatch.com/news/chf-end-cost-offset-rule 2019-01-17T16:00:01+11:00 https://pharmadispatch.com/news/a-relationship-that-works-for-patients 2019-01-18T16:00:01+11:00 https://pharmadispatch.com/news/pharmaxis-updates-on-loxl2-studies 2019-01-18T16:00:01+11:00 https://pharmadispatch.com/news/clock-ticking-as-caretaker-approaches 2019-01-18T04:34:01+11:00 https://pharmadispatch.com/news/greg-hunt-pushes-sector-on-cmi-access 2019-01-21T16:00:01+11:00 https://pharmadispatch.com/news/no-easy-solution-to-fill-ma-vacancies 2019-01-21T16:00:01+11:00 https://pharmadispatch.com/news/department-delays-further-discussion-on-payment-reform 2019-01-21T16:00:01+11:00 https://pharmadispatch.com/news/who-is-ready-for-rcas-p2p-cycle-challenge 2019-01-21T16:00:01+11:00 https://pharmadispatch.com/news/eisais-gary-hendler-on-australia-investment-and-a-pragmatic-appr 2019-01-22T16:00:01+11:00 https://pharmadispatch.com/news/industry-preparing-submissions-on-nps-review 2019-01-22T16:00:01+11:00 https://pharmadispatch.com/news/ma-concern-over-ad-hoc-pbs-reviews 2019-01-22T16:00:01+11:00 https://pharmadispatch.com/news/bayer-welcomes-government-funding-to-extend-heart-of-australia 2019-01-23T16:00:01+11:00 https://pharmadispatch.com/news/australia-hosts-meeting-of-global-leadership-team 2019-01-23T16:00:01+11:00 https://pharmadispatch.com/news/rob-hetherington-announces-gilead-departure 2019-01-23T16:00:01+11:00 https://pharmadispatch.com/news/eisais-gary-hendler-dealing-with-brexit-the-cost-of-doing-busine 2019-01-24T16:00:01+11:00 https://pharmadispatch.com/news/in-2019-the-smart-country-that-is-australia-owes-nothing-to-luck 2019-01-24T16:00:01+11:00 https://pharmadispatch.com/news/a-review-that-is-not-a-post-market-review 2019-01-25T16:00:01+11:00 https://pharmadispatch.com/news/industry-executive-to-lead-regeneus 2019-01-24T16:00:01+11:00 https://pharmadispatch.com/news/this-is-what-constitutes-a-pricing-negotiation-in-2019 2019-01-25T16:00:01+11:00 https://pharmadispatch.com/news/ma-extends-advisory-council-pending-board-election 2019-01-25T16:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-announces-february-listings-for-psoriasis 2019-01-25T16:00:01+11:00 https://pharmadispatch.com/news/challenging-discussions-ma-secures-some-concessions-on-new-fees 2019-01-30T16:00:01+11:00 https://pharmadispatch.com/news/pharmadispatch-2019-barbara-weisel-on-australia 2019-01-29T16:00:01+11:00 https://pharmadispatch.com/news/need-for-a-quorum-could-force-ma-hand-on-vacancies 2019-01-29T16:00:01+11:00 https://pharmadispatch.com/news/industry-backs-pbac-reappointment 2019-01-29T16:00:01+11:00 https://pharmadispatch.com/news/janssen-still-leading-the-way-on-pharmacup2019 2019-01-29T16:00:01+11:00 https://pharmadispatch.com/news/thriving-or-surviving-and-the-challenge-of-balance 2019-01-29T16:00:01+11:00 https://pharmadispatch.com/news/new-fees-deliver-double-hit-for-vaccine-companies 2019-01-30T16:00:01+11:00 https://pharmadispatch.com/news/government-welcomes-more-collaborations 2019-01-30T16:00:01+11:00 https://pharmadispatch.com/news/new-report-highlights-the-cost-of-medicine-misuse 2019-01-31T15:00:01+11:00 https://pharmadispatch.com/news/preventable-deaths-decline-but-more-to-be-done 2019-01-31T15:00:01+11:00 https://pharmadispatch.com/news/azs-pascal-soriot-my-australia-and-the-new-astrazeneca 2019-01-31T16:00:01+11:00 https://pharmadispatch.com/news/tga-to-host-cmi-meeting 2019-01-31T15:00:01+11:00 https://pharmadispatch.com/news/dennis-bastas-takes-full-ownership-ahead-of-arrotexmerger 2019-02-01T16:00:01+11:00 https://pharmadispatch.com/news/azs-pascal-soriot-on-pricing-patent-expiries-and-the-opportunity 2019-02-01T16:00:01+11:00 https://pharmadispatch.com/news/us-study-highlights-magnitude-of-rebates 2019-02-01T16:00:01+11:00 https://pharmadispatch.com/news/officials-confirm-relief-on-orphan-designation 2019-02-01T16:00:01+11:00 https://pharmadispatch.com/news/roche-takes-the-lead-in-pharmacup2019 2019-02-04T16:00:01+11:00 https://pharmadispatch.com/news/new-and-higher-fees-to-fund-changes-to-atagi 2019-02-04T16:00:01+11:00 https://pharmadispatch.com/news/pbs-fee-spike-driven-by-modelling-change 2019-02-04T16:00:01+11:00 https://pharmadispatch.com/news/the-gender-gap-on-flexibility 2019-02-04T16:00:01+11:00 https://pharmadispatch.com/news/australians-wait-as-uk-extends-funded-access-to-car-t 2019-02-05T16:00:01+11:00 https://pharmadispatch.com/news/the-challenge-of-achieving-balance 2019-02-05T16:00:01+11:00 https://pharmadispatch.com/news/company-concern-over-push-on-published-prices 2019-02-05T16:00:01+11:00 https://pharmadispatch.com/news/history-a-guide-on-how-companies-will-manage-hike 2019-02-05T16:00:01+11:00 https://pharmadispatch.com/news/the-boy-who-cried-wolf-on-confidentiality 2019-02-06T16:00:01+11:00 https://pharmadispatch.com/news/department-calls-pdl1-lung-cancer-meeting 2019-02-06T16:00:01+11:00 https://pharmadispatch.com/news/guild-scrap-1-pbs-prescription-discount 2019-02-06T16:00:01+11:00 https://pharmadispatch.com/news/nz-pm-pbs-comparisons-are-unfair 2019-02-07T16:00:01+11:00 https://pharmadispatch.com/news/ma-advisory-council-meets-for-first-time-in-2019 2019-02-07T16:00:01+11:00 https://pharmadispatch.com/news/new-funding-for-perth-based-phenome-centre 2019-02-07T16:00:01+11:00 https://pharmadispatch.com/news/new-pbs-leadership-takes-shape 2019-02-07T16:00:01+11:00 https://pharmadispatch.com/news/industry-looking-to-push-comparator-reform 2019-02-08T16:00:01+11:00 https://pharmadispatch.com/news/ma-and-ausbiotech-team-up-for-annual-luncheon 2019-02-08T16:00:01+11:00 https://pharmadispatch.com/news/roche-first-to-hit-10000-in-the-race-for-pharmacup2019 2019-02-08T16:00:01+11:00 https://pharmadispatch.com/news/ex-industry-executive-to-lead-nurses-association 2019-02-08T16:00:01+11:00 https://pharmadispatch.com/news/ma-board-to-decide-on-vacancies 2019-02-11T16:00:01+11:00 https://pharmadispatch.com/news/pd-l1-simplification-is-it-a-therapeutic-group 2019-02-11T16:00:01+11:00 https://pharmadispatch.com/news/sector-proposes-cmi-leaflet-redesign 2019-02-11T16:00:01+11:00 https://pharmadispatch.com/news/phrma-add-australia-to-trade-watch-list 2019-02-11T16:00:01+11:00 https://pharmadispatch.com/news/sigma-identifies-cost-efficiencies-as-merger-talks-continue 2019-02-12T16:00:01+11:00 https://pharmadispatch.com/news/australia-and-nz-hold-positions-in-global-ip-index 2019-02-12T16:00:01+11:00 https://pharmadispatch.com/news/government-should-delay-and-reconsider-rd-tax-cut 2019-02-12T16:00:01+11:00 https://pharmadispatch.com/news/not-stopping-the-roche-rangers-in-race-for-pharmacup2019 2019-02-12T16:00:01+11:00 https://pharmadispatch.com/news/new-local-leadership-for-allergan 2019-02-13T16:00:01+11:00 https://pharmadispatch.com/news/the-launch-of-a-new-industry-association 2019-02-13T16:00:01+11:00 https://pharmadispatch.com/news/companies-paying-the-price-of-supply-chain-payment-failure 2019-02-13T16:00:01+11:00 https://pharmadispatch.com/news/offer-a-reduction-and-we-will-be-more-receptive 2019-02-14T16:00:01+11:00 https://pharmadispatch.com/news/strong-result-for-csl 2019-02-14T16:00:01+11:00 https://pharmadispatch.com/news/a-relationship-that-masks-a-difficult-reality 2019-02-14T16:00:01+11:00 https://pharmadispatch.com/news/guild-absorbing-psa-joining-the-7cpa 2019-02-14T16:00:01+11:00 https://pharmadispatch.com/news/department-to-pay-for-labors-health-reform-commission 2019-02-15T16:00:01+11:00 https://pharmadispatch.com/news/department-confirms-52-pbac-recommendations-still-unfunded 2019-02-15T16:00:01+11:00 https://pharmadispatch.com/news/is-this-an-evidence-based-system 2019-02-15T16:00:01+11:00 https://pharmadispatch.com/news/pharmac-responds-to-criticism-by-announcing-it-will-review-itsel 2019-02-15T16:00:01+11:00 https://pharmadispatch.com/news/bms-davide-piras-the-challenge-in-australia-is-not-dramatically- 2019-02-18T16:00:01+11:00 https://pharmadispatch.com/news/two-weeks-to-go-as-pharmacup2019-races-towards-record 2019-02-18T16:00:01+11:00 https://pharmadispatch.com/news/new-deputy-chair-for-medicines-australia 2019-02-18T16:00:01+11:00 https://pharmadispatch.com/news/no-reporting-or-commitment-efficiencies 2019-02-17T21:04:01+11:00 https://pharmadispatch.com/news/this-is-what-a-cost-recovery-customer-should-expect 2019-02-18T16:00:01+11:00 https://pharmadispatch.com/news/gileads-rob-hetherington-workplaces-have-come-such-a-long-way 2019-02-19T16:00:01+11:00 https://pharmadispatch.com/news/living-therapies-hundreds-in-development-across-2600-trials 2019-02-26T16:00:01+11:00 https://pharmadispatch.com/news/department-of-health-reveals-facts-on-key-listing-stage 2019-02-19T16:00:01+11:00 https://pharmadispatch.com/news/response-reveals-impact-of-higher-price-cut-threshold 2019-02-19T16:00:01+11:00 https://pharmadispatch.com/news/st-asia-announces-new-special-access-program 2019-02-19T16:00:01+11:00 https://pharmadispatch.com/news/an-outdated-system 2019-02-25T14:00:01+11:00 https://pharmadispatch.com/news/what-next-for-payment-reform 2019-02-20T16:00:01+11:00 https://pharmadispatch.com/news/new-report-calls-for-greater-focus-on-secondary-cv-events 2019-02-20T16:00:01+11:00 https://pharmadispatch.com/news/fee-crunch-for-smaller-companies-and-patient-populations 2019-02-20T16:00:01+11:00 https://pharmadispatch.com/news/partnership-to-manage-biomedical-translation-bridge-program 2019-02-20T16:00:01+11:00 https://pharmadispatch.com/news/ebos-reports-growth-as-it-prepares-for-chemist-warehouse 2019-02-21T16:00:01+11:00 https://pharmadispatch.com/news/ma-where-are-the-service-standards-and-kpis 2019-02-21T16:00:01+11:00 https://pharmadispatch.com/news/ma-appoints-two-new-board-members 2019-02-21T16:00:01+11:00 https://pharmadispatch.com/news/nine-month-post-pbac-process 2019-02-21T16:00:01+11:00 https://pharmadispatch.com/news/takeda-confirms-australian-leadership 2019-02-22T16:00:01+11:00 https://pharmadispatch.com/news/fate-of-rd-tax-reform-a-matter-for-election-winner-1 2019-02-22T16:00:01+11:00 https://pharmadispatch.com/news/minister-starts-new-round-of-listing-announcements 2019-02-22T16:00:01+11:00 https://pharmadispatch.com/news/companies-set-to-pass-pharmacup2019-record 2019-02-22T16:00:01+11:00 https://pharmadispatch.com/news/david-quilty-retires-from-pharmacyguild 2019-02-23T02:28:01+11:00 https://pharmadispatch.com/news/pharmaxis-doses-first-patient-in-lox-inhibitor-trial 2019-02-25T16:00:01+11:00 https://pharmadispatch.com/news/government-acts-to-accelerate-cancer-listings 2019-02-25T14:00:01+11:00 https://pharmadispatch.com/news/janssen-surges-ahead-in-pharmacup2019 2019-02-25T16:00:01+11:00 https://pharmadispatch.com/news/trial-results-give-hope-on-peanut-allergy 2019-02-26T16:00:01+11:00 https://pharmadispatch.com/news/push-for-companies-to-provide-new-trial-data-to-pbs 2019-02-25T14:00:01+11:00 https://pharmadispatch.com/news/companies-recognised-for-gender-equality 2019-02-25T16:00:01+11:00 https://pharmadispatch.com/news/new-testing-means-patients-no-longer-defined-by-their-symptoms 2019-02-26T16:00:01+11:00 https://pharmadispatch.com/news/hepatitis-australia-raises-concerns-over-new-pbs-fees-and-submis 2019-02-26T16:00:01+11:00 https://pharmadispatch.com/news/they-will-impact-the-entire-system 2019-02-27T16:00:01+11:00 https://pharmadispatch.com/news/department-proceeding-with-next-step-in-the-process 2019-02-27T16:00:01+11:00 https://pharmadispatch.com/news/government-sets-industry-objective-for-new-10-year-mission-for-c 2019-02-27T16:00:01+11:00 https://pharmadispatch.com/news/companies-hit-target-with-three-days-to-go 2019-02-27T16:00:01+11:00 https://pharmadispatch.com/news/industry-leaders-front-us-senate-over-pricing 2019-02-27T16:00:01+11:00 https://pharmadispatch.com/news/ma-system-disconnect-and-not-yet-fit-for-purpose 2019-02-28T16:00:01+11:00 https://pharmadispatch.com/news/funding-for-take-home-naloxone-program 2019-02-28T16:00:01+11:00 https://pharmadispatch.com/news/more-leadership-change-for-pharmacy 2019-02-28T16:00:01+11:00 https://pharmadispatch.com/news/companies-race-past-130000-for-rare-cancers-australia 2019-03-01T16:00:01+11:00 https://pharmadispatch.com/news/another-listing-for-immunotherapy-combination 2019-03-01T16:00:01+11:00 https://pharmadispatch.com/news/lilly-welcomes-new-listing-for-il-17a-inhibitor 2019-03-01T01:39:01+11:00 https://pharmadispatch.com/news/pbs-listing-for-gileads-hiv-triple-combination 2019-03-01T16:00:01+11:00 https://pharmadispatch.com/news/industry-raises-over-200000-as-a-new-name-takes-the-pharmacup 2019-03-04T16:00:01+11:00 https://pharmadispatch.com/news/gilead-announces-interim-general-manager 2019-03-04T16:00:01+11:00 https://pharmadispatch.com/news/ma-to-decide-on-confirmed-board-vacancy 2019-03-04T16:00:01+11:00 https://pharmadispatch.com/news/talks-to-resume-on-friendless-reform 2019-03-04T16:00:01+11:00 https://pharmadispatch.com/news/positive-pathways-and-not-priorities 2019-03-04T16:00:01+11:00 https://pharmadispatch.com/news/coroner-calls-for-wide-availability-of-naloxone-nasal-spray 2019-03-05T16:00:01+11:00 https://pharmadispatch.com/news/growth-plan-for-terrywhite-chemmart 2019-03-05T16:00:01+11:00 https://pharmadispatch.com/news/new-pbac-appointments-with-more-to-come 2019-03-04T22:52:01+11:00 https://pharmadispatch.com/news/applications-open-for-bi-and-lilly-backed-grants 2019-03-05T16:00:01+11:00 https://pharmadispatch.com/news/msds-michael-azrak-a-pay-equity-ambassador 2019-03-05T16:00:01+11:00 https://pharmadispatch.com/news/dont-wait-to-be-heard-tell-your-own-story 2019-03-08T16:00:01+11:00 https://pharmadispatch.com/news/is-it-really-that-simple 2019-03-06T16:00:01+11:00 https://pharmadispatch.com/news/different-diseases-different-pathways-different-outcomes 2019-03-06T00:14:01+11:00 https://pharmadispatch.com/news/uk-launches-national-genome-health-strategy 2019-03-06T16:00:01+11:00 https://pharmadispatch.com/news/the-gender-gap-on-harassment-and-discrimination-at-work 2019-03-08T16:00:01+11:00 https://pharmadispatch.com/news/sanofi-disappointment-over-flu-vaccine-decision 2019-03-07T16:00:01+11:00 https://pharmadispatch.com/news/hunt-in-pre-election-pitch-to-pharmacy 2019-03-07T16:00:01+11:00 https://pharmadispatch.com/news/labor-goes-early-in-backing-pharmacy 2019-03-07T16:00:01+11:00 https://pharmadispatch.com/news/recognition-for-ma-continuing-education-program-awards 2019-03-07T16:00:01+11:00 https://pharmadispatch.com/news/mundipharmas-jane-orr-wider-availability-the-only-solution 2019-03-12T16:00:01+11:00 https://pharmadispatch.com/news/where-is-the-money-coming-from-1 2019-03-08T16:00:01+11:00 https://pharmadispatch.com/news/gbma-confirms-dates-for-first-biosimilar-awareness-week 2019-03-08T04:20:01+11:00 https://pharmadispatch.com/news/gsk-announces-new-leadership 2019-03-08T16:00:01+11:00 https://pharmadispatch.com/news/new-criteria-means-virtual-elimination-of-special-pricing-arrang 2019-03-11T16:00:01+11:00 https://pharmadispatch.com/news/red-book-a-bigger-worry-than-mccormack 2019-03-11T16:00:01+11:00 https://pharmadispatch.com/news/ma-decides-to-stick-with-ten 2019-03-11T16:00:01+11:00 https://pharmadispatch.com/news/possible-simplification-of-hcv-prescribing-as-uptake-slumps-furt 2019-03-11T16:00:01+11:00 https://pharmadispatch.com/news/our-current-concept-of-aging-is-wrong 2019-03-11T16:00:01+11:00 https://pharmadispatch.com/news/new-criteria-a-huge-gamble-that-will-test-industrys-patience-wit 2019-03-12T16:00:01+11:00 https://pharmadispatch.com/news/jj-launches-womens-leadership-and-inclusion-network 2019-03-12T16:00:01+11:00 https://pharmadispatch.com/news/research-reveals-potential-for-early-alzheimers-test 2019-03-12T16:00:01+11:00 https://pharmadispatch.com/news/msds-keytruda-secures-11th-approved-indication 2019-03-12T16:00:01+11:00 https://pharmadispatch.com/news/a-lean-decade-for-pbs-even-compared-to-pharmac 2019-03-13T16:00:01+11:00 https://pharmadispatch.com/news/the-choice-for-government-might-be-higher-prices-or-access-delay 2019-03-13T16:00:01+11:00 https://pharmadispatch.com/news/vertex-looking-ahead-on-symdeko 2019-03-13T16:00:01+11:00 https://pharmadispatch.com/news/us-agreement-for-perth-based-zelda-therapeutics 2019-03-13T05:26:01+11:00 https://pharmadispatch.com/news/cost-recovery-regulations-under-review 2019-03-14T16:00:01+11:00 https://pharmadispatch.com/news/government-backs-new-10-year-stem-cell-mission 2019-03-14T16:00:01+11:00 https://pharmadispatch.com/news/new-therapies-face-workarounds-through-existing-pathways 2019-03-14T16:00:01+11:00 https://pharmadispatch.com/news/digital-health-agency-backs-hospital-medication-trial 2019-03-14T16:00:01+11:00 https://pharmadispatch.com/news/api-sigma-has-chosen-a-path-to-downsize 2019-03-14T16:00:01+11:00 https://pharmadispatch.com/news/companies-to-pay-at-least-twice-for-an-spa 2019-03-14T16:00:01+11:00 https://pharmadispatch.com/news/new-spa-could-deliver-a-decade-of-cascading-price-cuts 2019-03-14T17:51:01+11:00 https://pharmadispatch.com/news/csl-renews-stem-partnership-with-national-youth-science-forum 2019-03-15T00:07:01+11:00 https://pharmadispatch.com/news/bms-does-the-blend-and-spin 2019-03-15T16:00:01+11:00 https://pharmadispatch.com/news/who-is-thinking-about-the-future 2019-03-18T16:00:01+11:00 https://pharmadispatch.com/news/labor-attitude-on-spas-probably-more-important-than-greg-hunts 2019-03-18T16:00:01+11:00 https://pharmadispatch.com/news/sector-to-unite-in-push-for-accounting-change 2019-03-17T23:49:01+11:00 https://pharmadispatch.com/news/btf-backs-creation-of-new-perth-based-biotech 2019-03-18T16:00:01+11:00 https://pharmadispatch.com/news/npsa-wholesalers-undervalued-even-with-cso 2019-03-18T16:00:01+11:00 https://pharmadispatch.com/news/wh-will-drive-discussions-about-cell-and-gene-therapies 2019-03-21T16:00:01+11:00 https://pharmadispatch.com/news/therapeutic-groups-may-not-deliver-like-they-once-did 2019-03-19T02:17:01+11:00 https://pharmadispatch.com/news/grattan-proposes-pbs-savings-for-dental-scheme 2019-03-19T16:00:01+11:00 https://pharmadispatch.com/news/extending-the-promise-of-immunotherapy 2019-03-21T16:00:01+11:00 https://pharmadispatch.com/news/new-listings-for-april-as-caretaker-approaches 2019-03-19T03:56:01+11:00 https://pharmadispatch.com/news/tga-no-impact-on-medicine-supply-with-no-deal-brexit 2019-03-19T16:00:01+11:00 https://pharmadispatch.com/news/sta-welcomes-breast-cancer-approval 2019-03-19T16:00:01+11:00 https://pharmadispatch.com/news/new-analysis-highlights-focus-on-pbs 2019-03-20T16:00:01+11:00 https://pharmadispatch.com/news/a-focus-on-new-listings-in-the-absence-of-anything-else 2019-03-20T16:00:01+11:00 https://pharmadispatch.com/news/2019-bridgetech-program-officially-underway 2019-03-20T08:07:01+11:00 https://pharmadispatch.com/news/fda-confirms-partial-clinical-hold-on-australian-developed-cance 2019-03-20T16:00:01+11:00 https://pharmadispatch.com/news/marcus-blackmore-returns-to-lead-company 2019-03-21T16:00:01+11:00 https://pharmadispatch.com/news/pfizer-hits-the-bay-run-for-clean-up-australia-day 2019-03-21T16:00:01+11:00 https://pharmadispatch.com/news/gsk-announces-australian-winners-of-research-challenge 2019-03-21T16:00:01+11:00 https://pharmadispatch.com/news/sigma-sales-of-hcv-therapies-halve 2019-03-22T16:00:01+11:00 https://pharmadispatch.com/news/ex-labor-senator-signs-up-with-former-health-minister 2019-03-22T16:00:01+11:00 https://pharmadispatch.com/news/ma-building-capacity-and-capability-on-living-therapies 2019-03-22T16:00:01+11:00 https://pharmadispatch.com/news/lung-the-leading-cause-of-cancer-mortality-in-2019 2019-03-22T16:14:01+11:00 https://pharmadispatch.com/news/biogen-and-eisai-scrap-development-of-aducanumab 2019-03-25T16:00:01+11:00 https://pharmadispatch.com/news/gsk-locals-join-global-colleagues-in-trek-for-kids 2019-03-25T16:00:01+11:00 https://pharmadispatch.com/news/documents-raise-questions-over-decision-timeline 2019-03-24T21:08:01+11:00 https://pharmadispatch.com/news/greg-hunt-seeks-advice-on-pre-pbac-funding 2019-03-25T16:00:01+11:00 https://pharmadispatch.com/news/article-cites-unnamed-experts-in-pbs-influence-claims 2019-03-25T16:00:01+11:00 https://pharmadispatch.com/news/patients-await-final-piece-in-the-funding-puzzle 2019-03-25T16:00:01+11:00 https://pharmadispatch.com/news/another-term-for-pbac-chair 2019-03-26T16:00:01+11:00 https://pharmadispatch.com/news/is-this-factor-f-or-just-another-announcement 2019-03-26T16:00:01+11:00 https://pharmadispatch.com/news/nominations-open-for-research-awards 2019-03-26T12:25:01+11:00 https://pharmadispatch.com/news/guild-warns-against-increased-dispensing-quantities 2019-03-27T16:00:01+11:00 https://pharmadispatch.com/news/proud-of-the-performance-but-humbled-by-the-impact 2019-03-27T16:00:01+11:00 https://pharmadispatch.com/news/roche-extremely-disappointed-over-msac-rejection 2019-03-27T05:35:01+11:00 https://pharmadispatch.com/news/confusion-of-the-definition-of-funded-access 2019-03-27T16:00:01+11:00 https://pharmadispatch.com/news/should-we-add-tumour-agnostic-to-pan-tumour 2019-03-28T16:00:01+11:00 https://pharmadispatch.com/news/tumour-agnostic-medicines-will-pose-a-new-reimbursement-challeng 2019-03-28T01:48:01+11:00 https://pharmadispatch.com/news/guild-staggered-astonishment-and-anger-over-near-catastrophe 2019-03-28T02:21:01+11:00 https://pharmadispatch.com/news/months-of-disagreement-over-banked-savings-measure 2019-03-28T16:00:01+11:00 https://pharmadispatch.com/news/pharmacy-will-never-accept-what-industry-lives-with 2019-03-29T16:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-encourages-people-to-join-bio-delegation 2019-03-29T16:00:01+11:00 https://pharmadispatch.com/news/guild-remember-flu-shot 2019-03-29T16:00:01+11:00 https://pharmadispatch.com/news/juno-acquires-injectables-from-az 2019-03-29T16:00:01+11:00 https://pharmadispatch.com/news/this-proposal-was-just-another-pbs-savings-measure 2019-04-01T16:00:01+11:00 https://pharmadispatch.com/news/what-will-budget-say-about-supply-chain-reform 2019-04-01T16:00:01+11:00 https://pharmadispatch.com/news/richard-vines-how-will-systems-cope 2019-04-01T16:00:01+11:00 https://pharmadispatch.com/news/labor-wait-and-see-on-dispensing-change 2019-04-01T16:00:01+11:00 https://pharmadispatch.com/news/lundbecks-michal-srensen-on-investing-to-grow 2019-04-02T16:00:01+11:00 https://pharmadispatch.com/news/how-and-when-does-this-therapy-come-to-australia 2019-04-02T16:00:01+11:00 https://pharmadispatch.com/news/no-dhl-in-new-cso-contracts 2019-04-01T16:00:01+11:00 https://pharmadispatch.com/news/pfizer-boss-refutes-lyrica-criticism 2019-04-01T02:03:01+11:00 https://pharmadispatch.com/news/ustr-restates-criticism-of-australia-and-nz 2019-04-02T16:00:01+11:00 https://pharmadispatch.com/news/subtle-but-important-change-in-new-listing-claim 2019-04-02T16:00:01+11:00 https://pharmadispatch.com/news/ma-says-review-required-to-ensure-patient-access 2019-04-03T16:00:01+11:00 https://pharmadispatch.com/news/government-sticks-with-supply-chain-reform 2019-04-03T06:00:01+11:00 https://pharmadispatch.com/news/pbs-confirmed-as-the-poor-cousin 2019-04-03T16:00:01+11:00 https://pharmadispatch.com/news/budget-reveals-impact-on-individual-products 2019-04-03T16:00:01+11:00 https://pharmadispatch.com/news/budget-2019-20-the-measures 2019-04-03T16:00:01+11:00 https://pharmadispatch.com/news/budget-surprise-as-rebate-revenue-goes-to-zero 2019-04-04T16:00:01+11:00 https://pharmadispatch.com/news/planned-reduction-in-post-pbac-timeline-stalls 2019-04-04T16:00:01+11:00 https://pharmadispatch.com/news/new-report-highlights-the-cost-of-pain 2019-04-04T16:00:01+11:00 https://pharmadispatch.com/news/hepatitis-australia-urgent-action-required-as-elimination-goal-s 2019-04-04T16:00:01+11:00 https://pharmadispatch.com/news/department-snubs-industry-concerns-over-spa-criteria 2019-04-05T16:00:01+11:00 https://pharmadispatch.com/news/actinogen-appoints-pharmaxis-chair 2019-04-05T16:00:01+11:00 https://pharmadispatch.com/news/has-the-pbs-ever-been-more-capped 2019-04-05T16:00:01+11:00 https://pharmadispatch.com/news/ma-welcomes-labors-cancer-pledge 2019-04-05T16:00:01+11:00 https://pharmadispatch.com/news/pharmac-fronts-parliamentary-inquiry 2019-04-09T15:00:01+10:00 https://pharmadispatch.com/news/18-medicines-recommended-but-not-listed 2019-04-05T20:36:01+11:00 https://pharmadispatch.com/news/compounders-call-to-scrap-payment-reform 2019-04-08T15:00:01+10:00 https://pharmadispatch.com/news/ma-calls-for-urgent-political-intervention-on-new-criteria 2019-04-08T15:00:01+10:00 https://pharmadispatch.com/news/the-pbs-is-now-a-political-football-dont-let-it-go-uncontested 2019-04-08T15:00:01+10:00 https://pharmadispatch.com/news/when-did-this-become-a-thing 2019-04-08T15:00:01+10:00 https://pharmadispatch.com/news/budget-cut-to-wholesaler-hospital-remuneration 2019-04-08T15:00:01+10:00 https://pharmadispatch.com/news/the-value-in-prescribing-program-targeting-bdmards 2019-04-09T15:00:01+10:00 https://pharmadispatch.com/news/applications-open-for-seqirus-immunisation-grants 2019-04-09T15:00:01+10:00 https://pharmadispatch.com/news/labor-extends-cancer-commitment-to-clinical-trials 2019-04-09T15:00:01+10:00 https://pharmadispatch.com/news/bio-add-australia-to-ip-watch-list 2019-04-09T15:00:01+10:00 https://pharmadispatch.com/news/some-nerves-over-cost-recovery-regulations 2019-04-10T15:00:01+10:00 https://pharmadispatch.com/news/alcon-restarts-life-as-an-independent-company 2019-04-10T15:00:01+10:00 https://pharmadispatch.com/news/recognition-for-ma-chair 2019-04-10T15:00:01+10:00 https://pharmadispatch.com/news/sector-facing-an-uncomfortable-reality 2019-04-10T15:00:01+10:00 https://pharmadispatch.com/news/anao-with-a-special-interest-in-spa-criteria 2019-04-11T15:00:01+10:00 https://pharmadispatch.com/news/patients-slam-government-mps-blocking-pharmac-inquiry 2019-04-11T15:00:01+10:00 https://pharmadispatch.com/news/leading-clinicians-welcomes-new-parkinsons-treatment 2019-04-11T15:00:01+10:00 https://pharmadispatch.com/news/merck-confirms-office-relocation 2019-04-11T15:00:01+10:00 https://pharmadispatch.com/news/ma-secures-major-commitments-from-greg-hunt 2019-04-11T15:00:01+10:00 https://pharmadispatch.com/news/election-imminent-has-final-decisions-emerge 2019-04-11T15:00:01+10:00 https://pharmadispatch.com/news/australias-rd-program-works-but-we-cant-rest-on-our-laurels 2019-04-12T15:00:01+10:00 https://pharmadispatch.com/news/pharmadispatch-2019-and-the-federal-election 2019-04-12T15:00:01+10:00 https://pharmadispatch.com/news/it-might-be-caretakers-but-the-announcements-may-not-be-over 2019-04-12T15:00:01+10:00 https://pharmadispatch.com/news/the-new-prana-starts-investor-roadshow 2019-04-12T15:00:01+10:00 https://pharmadispatch.com/news/bms-shareholders-back-celgene-acquisition 2019-04-15T15:00:01+10:00 https://pharmadispatch.com/news/another-blow-as-msd-pulls-hcv-promotion 2019-04-15T15:00:01+10:00 https://pharmadispatch.com/news/trade-agreements-could-save-the-pbs 2019-04-15T15:00:01+10:00 https://pharmadispatch.com/news/process-to-allow-choice-of-drug-at-the-discretion-of-the-clinici 2019-04-15T15:00:01+10:00 https://pharmadispatch.com/news/funding-and-local-manufacturing-for-novartis-car-t-therapy 2019-04-15T19:35:01+10:00 https://pharmadispatch.com/news/more-intervention-may-be-needed-on-gene-therapies 2019-04-16T15:00:01+10:00 https://pharmadispatch.com/news/making-the-case-for-us-australia-plus 2019-04-16T15:00:01+10:00 https://pharmadispatch.com/news/seqirus-proud-to-supply-flu-vaccine-to-nip 2019-04-16T15:00:01+10:00 https://pharmadispatch.com/news/hepatitis-australia-need-for-action-as-the-task-just-got-more-di 2019-04-16T15:00:01+10:00 https://pharmadispatch.com/news/data-on-out-of-pocket-costs-paints-a-very-mixed-picture 2019-04-16T23:38:01+10:00 https://pharmadispatch.com/news/ausbiotech-laments-the-wearisome-uncertainty-over-fate-of-rd-tax 2019-04-17T15:00:01+10:00 https://pharmadispatch.com/news/jacinda-ardern-work-to-be-done-on-pharmac 2019-04-17T15:00:01+10:00 https://pharmadispatch.com/news/new-study-reveals-positive-news-for-bis-pradaxa 2019-04-17T15:00:01+10:00 https://pharmadispatch.com/news/pfizer-and-jj-partner-to-support-lgbtqi-colleagues 2019-04-17T15:00:01+10:00 https://pharmadispatch.com/news/labor-commits-to-early-access-trials 2019-04-17T19:06:01+10:00 https://pharmadispatch.com/news/pefo-confirms-ma-secured-atagi-fee-delay 2019-04-18T15:00:01+10:00 https://pharmadispatch.com/news/right-to-trial-in-blood-cancers-a-limited-version-of-trumps-righ 2019-04-18T15:00:01+10:00 https://pharmadispatch.com/news/ma-starts-communication-on-principles-code 2019-04-18T15:00:01+10:00 https://pharmadispatch.com/news/pfizer-goes-red-for-world-haemophilia-day 2019-04-18T15:00:01+10:00 https://pharmadispatch.com/news/new-details-confirm-pre-election-rush-to-approve-car-t 2019-04-23T15:00:01+10:00 https://pharmadispatch.com/news/msac-strategic-decisions-needed-with-emerging-gene-therapies 2019-04-23T15:00:01+10:00 https://pharmadispatch.com/news/is-that-really-funding-early-access-to-treatment 2019-04-23T15:00:01+10:00 https://pharmadispatch.com/news/researchers-propose-biosimilar-price-regulation-over-uptake 2019-04-23T15:00:01+10:00 https://pharmadispatch.com/news/meaningless-assessment-evidence-of-the-need-for-change 2019-04-24T15:00:01+10:00 https://pharmadispatch.com/news/discussions-on-process-improvements-grind-to-a-halt 2019-04-24T15:00:01+10:00 https://pharmadispatch.com/news/overseas-access-funded-as-patients-await-local-approval 2019-04-24T15:00:01+10:00 https://pharmadispatch.com/news/forum-to-consider-a-new-approach-to-cancer-medicines 2019-04-26T15:00:01+10:00 https://pharmadispatch.com/news/expansion-in-the-us-but-still-no-news-on-australia 2019-04-26T15:00:01+10:00 https://pharmadispatch.com/news/election-means-wait-for-nps-review-outcome 2019-04-26T15:00:01+10:00 https://pharmadispatch.com/news/pbac-says-yes-to-roche-lung-cancer-combination 2019-04-29T15:00:01+10:00 https://pharmadispatch.com/news/another-call-for-fast-action-to-help-opiate-users 2019-04-29T15:00:01+10:00 https://pharmadispatch.com/news/pbac-to-consider-significant-changes-for-hcv 2019-04-29T15:00:01+10:00 https://pharmadispatch.com/news/pbac-and-msd-at-odds-over-keytruda 2019-04-29T15:00:01+10:00 https://pharmadispatch.com/news/gbma-launches-2019-biosimilar-week 2019-04-29T01:03:01+10:00 https://pharmadispatch.com/news/pbac-says-ok-to-delist-some-hiv-medicines 2019-04-29T01:53:01+10:00 https://pharmadispatch.com/news/funding-for-trials-or-proven-treatments 2019-04-30T14:00:01+10:00 https://pharmadispatch.com/news/lsdp-funds-the-first-generic-therapy 2019-04-30T01:14:01+10:00 https://pharmadispatch.com/news/hepatitis-australia-welcomes-hcv-commitments 2019-04-30T14:00:01+10:00 https://pharmadispatch.com/news/ma-urges-caution-on-pbac-submission-guidelines 2019-04-30T14:01:01+10:00 https://pharmadispatch.com/news/new-report-highlights-changing-face-of-drug-development 2019-05-01T15:00:01+10:00 https://pharmadispatch.com/news/roche-says-change-required-for-new-technologies 2019-05-01T15:00:01+10:00 https://pharmadispatch.com/news/companies-ink-deal-in-england-to-find-hcv-patients 2019-05-01T15:00:01+10:00 https://pharmadispatch.com/news/new-australian-life-sciences-investment-fund 2019-05-01T15:00:01+10:00 https://pharmadispatch.com/news/the-days-of-australian-purchasing-power-are-coming-to-an-end 2019-05-01T15:00:01+10:00 https://pharmadispatch.com/news/pharmac-announces-overhaul-of-decision-making 2019-05-02T15:00:01+10:00 https://pharmadispatch.com/news/rare-cancers-australia-super-sizes-kosi-challenge 2019-05-02T15:00:01+10:00 https://pharmadispatch.com/news/novartis-secures-gilenya-extension-ahead-of-pbac-consideration 2019-05-02T15:00:01+10:00 https://pharmadispatch.com/news/lung-cancer-review-tops-july-pbac-agenda 2019-05-02T15:00:01+10:00 https://pharmadispatch.com/news/coalition-commits-to-cut-pbs-safety-net 2019-05-02T16:00:01+10:00 https://pharmadispatch.com/news/just-more-of-the-same-on-the-pbs 2019-05-03T15:00:01+10:00 https://pharmadispatch.com/news/promising-results-for-new-car-t-therapy 2019-05-03T15:00:01+10:00 https://pharmadispatch.com/news/gbma-education-closes-the-week-confirming-new-event 2019-05-03T15:00:01+10:00 https://pharmadispatch.com/news/the-coalitions-record-on-the-pbs-reveals-a-very-complex-picture 2019-05-06T14:00:01+10:00 https://pharmadispatch.com/news/the-language-has-changed-but-anything-else 2019-05-04T14:00:01+10:00 https://pharmadispatch.com/news/can-numbers-work-both-ways 2019-05-06T14:00:01+10:00 https://pharmadispatch.com/news/new-australian-leadership-for-novo-nordisk 2019-05-06T19:01:01+10:00 https://pharmadispatch.com/news/could-restoration-be-the-most-likely-change-under-labor 2019-05-07T15:00:01+10:00 https://pharmadispatch.com/news/bi-backing-new-stroke-research-grant 2019-05-07T15:00:01+10:00 https://pharmadispatch.com/news/new-partnership-targeting-the-most-untreatable-cancers 2019-05-07T15:00:01+10:00 https://pharmadispatch.com/news/reappointed-pbac-chair-to-discuss-the-second-term 2019-05-07T15:00:01+10:00 https://pharmadispatch.com/news/lundbeck-acquires-us-basedabide-therapeutics 2019-05-07T15:00:01+10:00 https://pharmadispatch.com/news/pfizer-launches-local-we-are-series 2019-05-07T15:00:01+10:00 https://pharmadispatch.com/news/another-demonstration-against-pharmac 2019-05-08T15:00:01+10:00 https://pharmadispatch.com/news/will-australian-decision-makers-accept-the-risk-and-spend-the-mo 2019-05-08T15:00:01+10:00 https://pharmadispatch.com/news/we-have-a-third-world-system-when-it-comes-to-medicines 2019-05-08T15:00:01+10:00 https://pharmadispatch.com/news/xanadu-trial-disappoints-for-actinogen-medical 2019-05-08T15:00:01+10:00 https://pharmadispatch.com/news/ma-ceo-time-for-change-is-now 2019-05-09T15:00:01+10:00 https://pharmadispatch.com/news/labor-proposes-rd-tax-collaboration-premium 2019-05-09T15:00:01+10:00 https://pharmadispatch.com/news/bms-hosts-oncology-collaboration-event 2019-05-09T15:00:01+10:00 https://pharmadispatch.com/news/pm-its-not-about-numbers-on-a-chart-or-on-a-ledger-its-about-the 2019-05-09T15:00:01+10:00 https://pharmadispatch.com/news/pharmac-chair-model-under-stress 2019-05-10T15:00:01+10:00 https://pharmadispatch.com/news/msac-the-process-for-everything-not-captured-by-pbac 2019-05-13T15:00:01+10:00 https://pharmadispatch.com/news/labor-to-explore-other-options-on-supply-chain-payment-reform 2019-05-10T15:00:01+10:00 https://pharmadispatch.com/news/bipartisan-commitment-to-review-of-the-national-medicines-policy 2019-05-10T15:00:01+10:00 https://pharmadispatch.com/news/labor-may-seek-to-negotiate-a-strategic-agreement-with-medicines 2019-05-10T15:00:01+10:00 https://pharmadispatch.com/news/groups-unite-in-call-for-political-backing-on-rd 2019-05-10T15:00:01+10:00 https://pharmadispatch.com/news/page-workshop-focuses-on-the-pay-equity-gap 2019-05-10T15:00:01+10:00 https://pharmadispatch.com/news/reflections-on-the-art-of-political-campaigning-and-advocacy 2019-05-13T15:00:01+10:00 https://pharmadispatch.com/news/time-to-be-ambitious-and-drive-the-change-rather-than-be-the-vic 2019-05-12T19:52:01+10:00 https://pharmadispatch.com/news/bluebird-bio-australia-not-in-current-plan 2019-05-13T15:00:01+10:00 https://pharmadispatch.com/news/pharmadispatch-2019-one-week-to-go 2019-05-13T15:00:01+10:00 https://pharmadispatch.com/news/npsa-welcomes-election-commitments 2019-05-13T15:00:01+10:00 https://pharmadispatch.com/news/fda-sticks-with-suffix-and-sets-high-bar-for-interchangeability 2019-05-14T15:00:01+10:00 https://pharmadispatch.com/news/nz-focus-moves-to-epipen-14-years-after-approval 2019-05-14T15:00:01+10:00 https://pharmadispatch.com/news/timely-access-not-so-simple-for-gene-an-cell-therapy 2019-05-14T15:00:01+10:00 https://pharmadispatch.com/news/mayne-hit-by-generics-competition 2019-05-15T14:00:01+10:00 https://pharmadispatch.com/news/new-research-reveals-pbac-attitudes-to-sponsor-hearings 2019-05-15T14:00:01+10:00 https://pharmadispatch.com/news/anao-tga-partially-effective-on-cost-recovery 2019-05-15T14:00:01+10:00 https://pharmadispatch.com/news/race-oncology-launches-trial-in-israel 2019-05-15T14:00:01+10:00 https://pharmadispatch.com/news/humira-secures-another-piece-in-humira-patent-puzzle 2019-05-16T15:00:01+10:00 https://pharmadispatch.com/news/address-pressure-points-to-address-technology-gaps 2019-05-16T15:00:01+10:00 https://pharmadispatch.com/news/is-it-really-a-national-medicines-policy 2019-05-17T15:00:01+10:00 https://pharmadispatch.com/news/car-t-funding-raise-serious-questions-over-equity 2019-05-16T15:00:01+10:00 https://pharmadispatch.com/news/nz-isolated-on-biogens-spinraza 2019-05-16T15:00:01+10:00 https://pharmadispatch.com/news/labor-commits-funding-to-boost-hcv-uptake 2019-05-17T15:00:01+10:00 https://pharmadispatch.com/news/csl-appoints-new-operations-leader 2019-05-17T15:00:01+10:00 https://pharmadispatch.com/news/bi-says-no-biosimilars-for-australia 2019-05-17T15:00:01+10:00 https://pharmadispatch.com/news/sta-adopts-unique-pack-tracking-for-medicines 2019-05-17T15:00:01+10:00 https://pharmadispatch.com/news/mercks-leah-goodman-says-the-long-term-is-now 2019-05-20T15:00:01+10:00 https://pharmadispatch.com/news/celltrion-announces-global-expansion-plan 2019-05-20T15:00:01+10:00 https://pharmadispatch.com/news/who-predicted-this 2019-05-20T15:00:01+10:00 https://pharmadispatch.com/news/pharmadispatch-2019-election-outcome-an-early-focus 2019-05-20T15:00:01+10:00 https://pharmadispatch.com/news/there-are-reviews-and-there-are-reviews 2019-05-21T15:00:01+10:00 https://pharmadispatch.com/news/new-unit-to-support-consumer-input 2019-05-21T15:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-marks-international-clinical-trials-day 2019-05-21T15:00:01+10:00 https://pharmadispatch.com/news/pbac-chair-review-should-consider-all-new-technologies 2019-05-22T15:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-calls-for-action-on-rd-tax-changes 2019-05-22T15:00:01+10:00 https://pharmadispatch.com/news/guild-says-doctors-misguided-and-ill-informed-on-flu-vax 2019-05-22T15:45:01+10:00 https://pharmadispatch.com/news/trade-and-the-pbs-a-first-time-challenge 2019-05-22T15:00:01+10:00 https://pharmadispatch.com/news/cost-recovery-resourcing-and-cost-offsets 2019-05-23T14:00:01+10:00 https://pharmadispatch.com/news/hcv-listing-no-netflix-deal 2019-05-23T14:00:01+10:00 https://pharmadispatch.com/news/supply-chain-payment-reform-mad 2019-05-23T14:00:01+10:00 https://pharmadispatch.com/news/msac-not-the-sole-solution-on-gene-and-cell-therapies 2019-05-24T15:00:01+10:00 https://pharmadispatch.com/news/we-will-not-agree-on-how-to-create-the-demise-of-their-business 2019-05-24T15:00:01+10:00 https://pharmadispatch.com/news/who-will-explain-what-more-money-in-the-pbs-actually-means 2019-05-24T15:00:01+10:00 https://pharmadispatch.com/news/kim-carr-will-not-nominate-for-shadow-ministry 2019-05-27T15:00:01+10:00 https://pharmadispatch.com/news/the-list-and-spend-conflict-makes-new-price-cuts-inevitable 2019-05-27T15:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-remains-in-health-as-pm-unveils-new-ministry 2019-05-26T19:03:01+10:00 https://pharmadispatch.com/news/fda-approves-new-gene-therapy-as-novartis-plans-global-launch 2019-05-27T15:00:01+10:00 https://pharmadispatch.com/news/australia-might-be-lucky-on-zolgensma 2019-05-27T15:00:01+10:00 https://pharmadispatch.com/news/do-you-value-a-lifetime-benefit-based-on-almost-no-evidence 2019-05-29T14:00:01+10:00 https://pharmadispatch.com/news/high-upfront-cost-but-decades-of-savings 2019-05-31T15:00:01+10:00 https://pharmadispatch.com/news/seqirus-signs-agreement-with-gedeon-richter 2019-05-27T15:00:01+10:00 https://pharmadispatch.com/news/sector-welcomes-new-ministry-and-hunt-reappointment-1 2019-05-27T15:00:01+10:00 https://pharmadispatch.com/news/more-flexibility-on-evaluation-pathways 2019-05-28T15:00:01+10:00 https://pharmadispatch.com/news/another-four-years-for-pbac-deputy-chair 2019-05-28T15:00:01+10:00 https://pharmadispatch.com/news/lung-foundation-issues-urgent-plea-on-vaccine 2019-05-28T15:00:01+10:00 https://pharmadispatch.com/news/ma-have-we-been-responsible-at-the-expense-of-our-viability 2019-05-28T15:00:01+10:00 https://pharmadispatch.com/news/someone-finally-explains-how-reform-will-work-or-wont 2019-05-29T14:00:01+10:00 https://pharmadispatch.com/news/pharmac-boss-shrugs-off-criticism 2019-05-29T14:00:01+10:00 https://pharmadispatch.com/news/shorten-wants-health-portfolio 2019-05-29T15:00:01+10:00 https://pharmadispatch.com/news/this-is-where-the-cost-offset-policy-ends 2019-05-30T15:00:01+10:00 https://pharmadispatch.com/news/biomarin-updates-on-haemophilia-gene-therapy 2019-05-30T15:00:01+10:00 https://pharmadispatch.com/news/merck-to-markworld-multiple-sclerosis-day 2019-05-30T15:00:01+10:00 https://pharmadispatch.com/news/bionomics-updates-on-strategic-review 2019-05-30T15:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-survey-reveals-worst-result-this-decade 2019-05-31T15:00:01+10:00 https://pharmadispatch.com/news/merger-of-two-leading-consultancies 2019-06-03T15:00:01+10:00 https://pharmadispatch.com/news/no-respite-for-medicines-in-nz-budget 2019-05-31T15:00:01+10:00 https://pharmadispatch.com/news/investors-cheer-patrys-in-response-to-trial-update 2019-05-31T15:00:01+10:00 https://pharmadispatch.com/news/one-of-the-industrys-longest-serving-leaders-is-retiring 2019-05-31T04:51:01+10:00 https://pharmadispatch.com/news/chris-bowen-appointed-shadow-health-minister 2019-06-03T15:00:01+10:00 https://pharmadispatch.com/news/another-meeting-and-still-no-agreement 2019-06-03T15:00:01+10:00 https://pharmadispatch.com/news/new-report-recommends-more-patient-involvement-in-pbs-decisions 2019-06-03T15:00:01+10:00 https://pharmadispatch.com/news/novo-nordisk-welcomes-new-diabetes-listing 2019-06-03T15:00:01+10:00 https://pharmadispatch.com/news/centre-stage-for-immunotherapies-at-asco 2019-06-04T15:00:01+10:00 https://pharmadispatch.com/news/uqs-uniquest-in-cancer-partnership-with-pfizer 2019-06-04T15:00:01+10:00 https://pharmadispatch.com/news/jo-watson-consider-update-of-2009-hta-review 2019-06-04T15:00:01+10:00 https://pharmadispatch.com/news/csl-seeking-applicants-for-125m-fellowships 2019-06-04T15:00:01+10:00 https://pharmadispatch.com/news/az-inks-new-deal-with-starpharma 2019-06-04T15:00:01+10:00 https://pharmadispatch.com/news/agreement-clears-the-way-for-second-biosimilar-rituximab 2019-06-04T01:34:01+10:00 https://pharmadispatch.com/news/should-consumers-input-to-decisions-or-be-able-to-change-them 2019-06-05T15:00:01+10:00 https://pharmadispatch.com/news/new-car-t-data-once-again-highlights-the-evaluation-challenge 2019-06-05T15:00:01+10:00 https://pharmadispatch.com/news/msd-launches-reconciliation-action-plan 2019-06-05T15:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-welcomes-shadow-ministry 2019-06-05T15:00:01+10:00 https://pharmadispatch.com/news/should-industry-truly-challenge-the-status-quo 2019-06-06T15:00:01+10:00 https://pharmadispatch.com/news/pharmac-we-get-advice-through-other-ways 2019-06-06T15:00:01+10:00 https://pharmadispatch.com/news/new-report-reveals-scale-of-us-industry 2019-06-06T15:00:01+10:00 https://pharmadispatch.com/news/bluebird-bio-secures-eu-approval-but-still-no-australia 2019-06-06T15:00:01+10:00 https://pharmadispatch.com/news/bms-announces-post-acquisition-leadership 2019-06-06T15:34:01+10:00 https://pharmadispatch.com/news/what-happens-when-there-are-no-competitors 2019-06-07T15:00:01+10:00 https://pharmadispatch.com/news/the-mystery-of-the-1-discount-review 2019-06-06T20:27:01+10:00 https://pharmadispatch.com/news/australian-company-progresses-immunotherapy-combination 2019-06-07T15:00:01+10:00 https://pharmadispatch.com/news/four-year-term-for-pbacs-industry-nominee 2019-06-07T15:00:01+10:00 https://pharmadispatch.com/news/msds-michael-azrak-review-must-be-ambitious-and-transformative 2019-06-11T15:00:01+10:00 https://pharmadispatch.com/news/recognition-in-queens-birthday-honours 2019-06-11T15:00:01+10:00 https://pharmadispatch.com/news/originator-biologic-wins-nz-tender 2019-06-11T15:00:01+10:00 https://pharmadispatch.com/news/there-are-gene-therapies-and-gene-therapies 2019-06-11T15:00:01+10:00 https://pharmadispatch.com/news/australia-moved-to-soften-price-transparency-demand 2019-06-12T15:00:01+10:00 https://pharmadispatch.com/news/transparency-debate-puts-australia-in-a-global-context 2019-06-12T15:00:01+10:00 https://pharmadispatch.com/news/when-was-opportunity-cost-adopted-in-pbs-decision-making 2019-06-12T15:00:01+10:00 https://pharmadispatch.com/news/merck-staff-preview-new-sydney-office 2019-06-12T15:00:01+10:00 https://pharmadispatch.com/news/where-was-the-frank-and-complete-discussion 2019-06-13T15:00:01+10:00 https://pharmadispatch.com/news/gene-technology-an-increasing-focus 2019-06-13T15:00:01+10:00 https://pharmadispatch.com/news/evidence-weaponised-through-opportunity-cost 2019-06-13T15:00:01+10:00 https://pharmadispatch.com/news/lack-of-investment-drivingback-room-deals 2019-06-14T15:00:01+10:00 https://pharmadispatch.com/news/new-technologies-exposing-flaws-in-hta 2019-06-14T15:00:01+10:00 https://pharmadispatch.com/news/response-on-the-use-of-opportunity-cost 2019-06-14T15:00:01+10:00 https://pharmadispatch.com/news/early-informed-and-high-quality-engagement-essential 2019-06-14T15:00:01+10:00 https://pharmadispatch.com/news/bluebird-bio-confirms-price-of-its-first-gene-therapy 2019-06-17T15:00:01+10:00 https://pharmadispatch.com/news/where-will-the-government-find-the-billions-for-new-listings 2019-06-17T15:00:01+10:00 https://pharmadispatch.com/news/will-it-require-another-factor-f-program 2019-06-17T15:00:01+10:00 https://pharmadispatch.com/news/pbac-pbac-may-intracycle-outcomes-outcomes 2019-06-17T15:00:01+10:00 https://pharmadispatch.com/news/the-cost-of-doing-nothing 2019-06-17T15:00:01+10:00 https://pharmadispatch.com/news/new-leadership-for-gilead-australia-and-nz 2019-06-18T15:00:01+10:00 https://pharmadispatch.com/news/emerging-companies-dominate-new-therapies 2019-06-18T15:00:01+10:00 https://pharmadispatch.com/news/patients-welcome-new-pain-national-strategy 2019-06-18T15:00:01+10:00 https://pharmadispatch.com/news/australian-patient-voice-initiative-highlighted-at-international 2019-06-18T15:00:01+10:00 https://pharmadispatch.com/news/pfizer-to-acquire-array-biopharma 2019-06-18T15:00:01+10:00 https://pharmadispatch.com/news/australian-advocate-to-chair-of-htai-patient-interest-group 2019-06-19T15:00:01+10:00 https://pharmadispatch.com/news/gsk-getting-back-into-gene-therapy 2019-06-19T15:00:01+10:00 https://pharmadispatch.com/news/formal-consideration-of-rationing-just-a-matter-of-time 2019-06-19T15:00:01+10:00 https://pharmadispatch.com/news/australia-at-risk-of-missing-hcv-elimination-target 2019-06-19T15:00:01+10:00 https://pharmadispatch.com/news/celgene-divests-immunotherapy-ahead-of-merger 2019-06-20T15:00:01+10:00 https://pharmadispatch.com/news/profound-change-required-to-integrate-precision-medicines 2019-06-20T15:00:01+10:00 https://pharmadispatch.com/news/another-country-approves-first-rnai-gene-therapy-still-no-austra 2019-06-20T15:00:01+10:00 https://pharmadispatch.com/news/divesting-in-older-technologies-will-be-required 2019-06-20T04:38:01+10:00 https://pharmadispatch.com/news/the-challenge-of-attracting-gene-and-cell-therapy-makers 2019-06-21T15:00:01+10:00 https://pharmadispatch.com/news/sill-no-sign-of-payment-reform-progress 2019-06-21T15:00:01+10:00 https://pharmadispatch.com/news/the-government-already-disinvests-in-old-pbs-technologies 2019-06-21T15:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-will-work-to-ensure-patient-access-to-gene-and-cell-th 2019-06-21T15:00:01+10:00 https://pharmadispatch.com/news/guild-announces-new-leadership 2019-06-21T21:58:01+10:00 https://pharmadispatch.com/news/biosimilars-start-to-deliver-on-price-disclosure 2019-06-24T15:00:01+10:00 https://pharmadispatch.com/news/government-faces-a-very-difficult-choice-on-pbs-future 2019-06-23T23:46:01+10:00 https://pharmadispatch.com/news/no-presence-means-no-internal-advocates 2019-06-24T15:00:01+10:00 https://pharmadispatch.com/news/flexibility-for-all-what-is-workplace-flexibility-really-and-why 2019-06-24T15:00:01+10:00 https://pharmadispatch.com/news/industry-prominent-in-annual-hr-awards 2019-06-24T15:00:01+10:00 https://pharmadispatch.com/news/a-possible-comeback-for-mwg 2019-06-25T15:00:01+10:00 https://pharmadispatch.com/news/race-to-commercialise-in-winner-take-all-market 2019-06-25T15:00:01+10:00 https://pharmadispatch.com/news/nz-industry-gathers-for-pivotal-week 2019-06-25T15:00:01+10:00 https://pharmadispatch.com/news/tumour-agnostic-therapies-both-in-approval-process 2019-06-25T03:43:01+10:00 https://pharmadispatch.com/news/who-remembers-the-first-red-tape-review 2019-06-25T15:00:01+10:00 https://pharmadispatch.com/news/more-required-to-attract-emerging-therapies 2019-06-26T15:00:01+10:00 https://pharmadispatch.com/news/recognition-for-sanofis-employee-well-being-program 2019-06-26T15:00:01+10:00 https://pharmadispatch.com/news/nz-poor-access-and-poor-outcomes 2019-06-26T15:00:01+10:00 https://pharmadispatch.com/news/the-cost-of-immunglobulin-is-on-the-rise 2019-06-27T15:00:01+10:00 https://pharmadispatch.com/news/new-report-highlights-myeloma-gap-for-nz-patients 2019-06-26T15:00:01+10:00 https://pharmadispatch.com/news/abbvie-announces-us63bn-acquisition-of-allergan 2019-06-26T15:00:01+10:00 https://pharmadispatch.com/news/nz-myeloma-patients-rely-on-hope-and-everything-other-than-pharm 2019-06-27T15:00:01+10:00 https://pharmadispatch.com/news/does-pharmac-serve-patients-or-itself 2019-06-27T15:00:01+10:00 https://pharmadispatch.com/news/nices-dillon-change-required-to-manage-the-coming-revolution-in- 2019-06-27T15:00:01+10:00 https://pharmadispatch.com/news/what-is-the-role-of-a-prescribing-authority 2019-07-10T15:00:01+10:00 https://pharmadispatch.com/news/if-you-want-more-groceries-you-need-to-spend-more-money 2019-06-28T15:00:01+10:00 https://pharmadispatch.com/news/bms-adds-to-diversity-and-inclusion-programs 2019-06-28T15:00:01+10:00 https://pharmadispatch.com/news/imc-recognised-for-collaboration-with-csl 2019-06-28T15:00:01+10:00 https://pharmadispatch.com/news/australian-company-progresses-immunotherapy 2019-06-28T15:00:01+10:00 https://pharmadispatch.com/news/patients-could-be-closer-to-securing-combination-therapy 2019-06-28T15:00:01+10:00 https://pharmadispatch.com/news/its-tough-pricing-life-for-patented-medicines 2019-07-01T15:00:01+10:00 https://pharmadispatch.com/news/pfizer-hosts-local-activation-of-impact2030 2019-06-29T01:55:01+10:00 https://pharmadispatch.com/news/former-fda-head-joins-pfizer-board 2019-07-01T15:00:01+10:00 https://pharmadispatch.com/news/biointelect-announces-new-collaboration 2019-07-02T15:00:01+10:00 https://pharmadispatch.com/news/a-bit-more-time-for-abbvies-kirsten-odoherty 2019-06-29T15:00:01+10:00 https://pharmadispatch.com/news/pbac-public-interest-in-knowing-our-view-on-each-medicine-being- 2019-07-01T15:00:01+10:00 https://pharmadispatch.com/news/up-and-coming-gene-therapies 2019-07-01T15:00:01+10:00 https://pharmadispatch.com/news/market-preparing-for-arrival-of-arrotex 2019-07-02T15:00:01+10:00 https://pharmadispatch.com/news/the-pbs-and-health-a-tale-of-two-decades 2019-07-02T15:00:01+10:00 https://pharmadispatch.com/news/pfizer-updates-on-dmd-race-with-sarepta-therapeutics 2019-07-02T15:00:01+10:00 https://pharmadispatch.com/news/why-have-the-pbs-and-medicare-taken-diametrically-opposed-paths 2019-07-03T15:00:01+10:00 https://pharmadispatch.com/news/australian-developed-ai-flu-vax-starts-trials-in-the-us 2019-07-03T15:00:01+10:00 https://pharmadispatch.com/news/a-global-walk-for-roche-australia 2019-07-03T15:00:01+10:00 https://pharmadispatch.com/news/theological-dogma-that-is-obsolete-and-not-humane 2019-07-03T15:00:01+10:00 https://pharmadispatch.com/news/anao-watching-pbs-on-rebate-complexity 2019-07-04T15:00:01+10:00 https://pharmadispatch.com/news/the-stark-example-of-pbs-transformation 2019-07-04T15:00:01+10:00 https://pharmadispatch.com/news/former-sirtex-ceo-pleads-guilty-to-insider-trading 2019-07-04T15:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-attributes-hiv-decline-to-funding-for-prep 2019-07-04T15:00:01+10:00 https://pharmadispatch.com/news/hospital-pharmacists-unhappy-over-confirmation-of-mark-up-cut 2019-07-04T15:00:01+10:00 https://pharmadispatch.com/news/report-highlights-strengths-and-weaknesses-on-gender-equity 2019-07-04T15:00:01+10:00 https://pharmadispatch.com/news/dr-john-bashford-redefining-the-future-for-rare-cancers 2019-07-05T15:00:01+10:00 https://pharmadispatch.com/news/more-scrutiny-of-hospital-pharmacy-is-inevitable 2019-07-05T15:00:01+10:00 https://pharmadispatch.com/news/without-prejudice-meeting-kicks-off-7cpa-consultations 2019-07-05T15:00:01+10:00 https://pharmadispatch.com/news/dr-john-bashford-strong-research-is-the-basis-for-market-access 2019-07-08T15:00:01+10:00 https://pharmadispatch.com/news/us-payers-impose-restrictions-on-gene-therapy 2019-07-05T03:45:01+10:00 https://pharmadispatch.com/news/documents-reveal-detail-and-extent-of-keytruda-dispute 2019-07-08T15:00:01+10:00 https://pharmadispatch.com/news/not-really-conflating-two-different-processes 2019-07-08T15:00:01+10:00 https://pharmadispatch.com/news/it-should-go-both-ways-on-clinical-trial-data 2019-07-08T15:00:01+10:00 https://pharmadispatch.com/news/reform-on-government-legislation-list-but-not-ready-to-go 2019-07-09T15:00:01+10:00 https://pharmadispatch.com/news/nz-radio-host-prepare-to-die-if-diagnosed-with-cancer 2019-07-09T15:00:01+10:00 https://pharmadispatch.com/news/new-paper-recommends-new-approach-to-vaccines 2019-07-09T15:00:01+10:00 https://pharmadispatch.com/news/gsk-will-try-again-but-not-optimistic-without-change 2019-07-09T15:00:01+10:00 https://pharmadispatch.com/news/next-generation-car-t-could-resolve-key-issue 2019-07-10T15:00:01+10:00 https://pharmadispatch.com/news/stalled-reform-will-happen-one-way-or-another 2019-07-10T15:00:01+10:00 https://pharmadispatch.com/news/a-busy-year-means-review-may-need-to-wait 2019-07-10T15:00:01+10:00 https://pharmadispatch.com/news/reform-faces-a-tough-parliamentary-reality 2019-07-11T15:00:01+10:00 https://pharmadispatch.com/news/different-types-of-gene-therapy-an-easier-funding-pathway-for-so 2019-07-11T15:00:01+10:00 https://pharmadispatch.com/news/impressive-stock-market-debut-for-new-perth-based-biopharma 2019-07-11T15:00:01+10:00 https://pharmadispatch.com/news/dennis-bastas-on-arrotex-the-largest-company-by-volume-in-pbs-hi 2019-07-11T15:00:01+10:00 https://pharmadispatch.com/news/new-chair-for-nps-medicinewise 2019-07-11T15:00:01+10:00 https://pharmadispatch.com/news/uk-first-identified-hta-issues-for-gene-and-cell-therapy-in-2012 2019-07-12T15:00:01+10:00 https://pharmadispatch.com/news/exclusive-reform-will-not-be-implemented-without-sector-agreemen 2019-07-12T15:00:01+10:00 https://pharmadispatch.com/news/no-agreement-and-issue-substantially-addressed-why-bother 2019-07-12T15:00:01+10:00 https://pharmadispatch.com/news/australian-company-prescient-initiates-trial-of-tumour-agnostic- 2019-07-12T15:00:01+10:00 https://pharmadispatch.com/news/is-this-farewell-to-preserving-prescriber-choice 2019-07-15T15:00:01+10:00 https://pharmadispatch.com/news/supply-chain-payment-reform-triggered-debate-over-an-even-more-c 2019-07-15T15:00:01+10:00 https://pharmadispatch.com/news/the-uniqure-experience-highlights-the-commercial-challenge 2019-07-15T15:00:01+10:00 https://pharmadispatch.com/news/does-hcv-decline-have-implications-for-supply-chain-reform 2019-07-15T15:00:01+10:00 https://pharmadispatch.com/news/imugene-acquires-rights-to-new-oncolytic-virus-technology 2019-07-16T15:00:01+10:00 https://pharmadispatch.com/news/focus-on-the-reality-rather-than-the-language 2019-07-16T15:00:01+10:00 https://pharmadispatch.com/news/patients-hope-new-inquiry-will-target-pharmac 2019-07-16T15:00:01+10:00 https://pharmadispatch.com/news/ma-considering-whether-to-drop-accc-authorisation 2019-07-16T15:00:01+10:00 https://pharmadispatch.com/news/bayer-venture-capital-arm-invests-in-off-the-shelf-car-t 2019-07-17T15:00:01+10:00 https://pharmadispatch.com/news/servier-in-new-collaboration-with-melbournes-biocurate 2019-07-17T15:00:01+10:00 https://pharmadispatch.com/news/how-do-we-even-know-what-patients-are-missing-out-on 2019-07-17T15:00:01+10:00 https://pharmadispatch.com/news/ma-simply-cannot-say-no-to-supply-chain-reform 2019-07-17T15:00:01+10:00 https://pharmadispatch.com/news/gilead-ups-stake-in-biotech-and-expands-cell-manufacturing 2019-07-17T15:00:01+10:00 https://pharmadispatch.com/news/phrma-the-risk-of-international-reference-pricing 2019-07-18T15:00:01+10:00 https://pharmadispatch.com/news/jj-innovation-recognises-undergraduates 2019-07-18T15:00:01+10:00 https://pharmadispatch.com/news/stakeholder-meeting-a-little-different-to-last-time 2019-07-18T15:00:01+10:00 https://pharmadispatch.com/news/takeda-from-car-t-to-off-the-shelf-icart 2019-07-18T15:00:01+10:00 https://pharmadispatch.com/news/gbma-confirms-its-first-biosimilar-member 2019-07-18T15:00:01+10:00 https://pharmadispatch.com/news/disappointment-for-australian-innovation 2019-07-19T15:00:01+10:00 https://pharmadispatch.com/news/boehringer-ingelheim-acquires-new-oncology-platform 2019-07-19T15:00:01+10:00 https://pharmadispatch.com/news/gene-and-cell-therapy-helps-boost-novartis-second-quarter 2019-07-19T15:00:01+10:00 https://pharmadispatch.com/news/japanese-pharma-moves-to-acquire-local-stem-cell-company 2019-07-22T15:00:01+10:00 https://pharmadispatch.com/news/achieving-greater-transparency-with-no-transparency 2019-07-22T15:00:01+10:00 https://pharmadispatch.com/news/the-parental-leave-experience-at-page-workshop 2019-07-22T15:00:01+10:00 https://pharmadispatch.com/news/not-enough-to-secure-streamlined-authority 2019-07-22T15:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-confirms-wider-access-to-kalydeco 2019-07-22T15:00:01+10:00 https://pharmadispatch.com/news/lillys-benjamin-basil-on-the-dream-opportunity 2019-07-25T15:00:01+10:00 https://pharmadispatch.com/news/can-we-escape-our-decision-making-safe-haven 2019-07-24T15:00:01+10:00 https://pharmadispatch.com/news/msd-welcomes-another-keytruda-indication 2019-07-23T15:00:01+10:00 https://pharmadispatch.com/news/stakeholders-gather-in-canberra-to-kick-off-7cpa-negotiation 2019-07-23T15:00:01+10:00 https://pharmadispatch.com/news/bms-australia-serving-soup-for-the-soul 2019-07-23T15:00:01+10:00 https://pharmadispatch.com/news/strategic-blueprint-the-future-focus-for-ma-strategy-day 2019-07-23T15:00:01+10:00 https://pharmadispatch.com/news/arrotex-announces-new-executive-team 2019-07-23T15:00:01+10:00 https://pharmadispatch.com/news/roche-brings-together-patient-leaders-in-canberra 2019-07-24T15:00:01+10:00 https://pharmadispatch.com/news/bayer-hosts-event-to-mark-international-self-care-day 2019-07-24T15:00:01+10:00 https://pharmadispatch.com/news/who-else-will-respond-to-technology-driven-change 2019-07-24T15:00:01+10:00 https://pharmadispatch.com/news/share-of-the-pbs-spend-highlights-funding-challenge 2019-07-25T15:00:01+10:00 https://pharmadispatch.com/news/industry-backs-event-to-correct-online-gender-bias 2019-07-25T15:00:01+10:00 https://pharmadispatch.com/news/terrywhite-chemmart-ceo-leads-trek-to-kokoda-for-cancer-funds 2019-07-25T15:00:01+10:00 https://pharmadispatch.com/news/clinicians-welcome-new-multiple-myeloma-combination 2019-07-25T15:00:01+10:00 https://pharmadispatch.com/news/is-flexibility-a-sign-of-the-systems-strength-or-does-it-expose- 2019-07-26T15:00:01+10:00 https://pharmadispatch.com/news/a-shrinking-piece-of-the-pie-to-fund-new-medicines 2019-07-26T15:00:01+10:00 https://pharmadispatch.com/news/taking-responsibility-for-comments-posted-on-social-media-assets 2019-07-26T15:00:01+10:00 https://pharmadispatch.com/news/doh-need-to-ensure-effectiveness-of-current-pbs-spend 2019-07-26T15:00:01+10:00 https://pharmadispatch.com/news/currrent-pbs-spend-will-not-be-enough-to-deliver-access 2019-07-26T15:00:01+10:00 https://pharmadispatch.com/news/pharmacy-guild-push-for-sector-mou 2019-07-29T15:00:01+10:00 https://pharmadispatch.com/news/psa-signs-mou-with-hospital-pharmacists 2019-07-29T15:00:01+10:00 https://pharmadispatch.com/news/a-smart-move-or-a-sign-of-changing-times 2019-07-29T15:00:01+10:00 https://pharmadispatch.com/news/new-zealand-opposition-commit-to-cancer-drug-fund 2019-07-29T15:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-adds-to-august-listings 2019-07-29T15:00:01+10:00 https://pharmadispatch.com/news/another-major-merger-set-to-be-announced 2019-07-29T19:41:01+10:00 https://pharmadispatch.com/news/deal-adds-to-the-evidence-of-an-industry-in-transformation 2019-07-30T15:00:01+10:00 https://pharmadispatch.com/news/australian-company-updates-on-neuroscience-trial 2019-07-30T15:00:01+10:00 https://pharmadispatch.com/news/no-point-adding-consumers-without-wider-reform 2019-07-31T14:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-returns-to-pbs-in-parliament 2019-07-30T15:00:01+10:00 https://pharmadispatch.com/news/pfizer-mylan-confirm-off-patent-merger 2019-07-30T15:00:01+10:00 https://pharmadispatch.com/news/is-a-variation-the-real-price-of-facilitation 2019-07-31T14:00:01+10:00 https://pharmadispatch.com/news/australians-urged-to-register-for-organ-donation 2019-07-31T14:00:01+10:00 https://pharmadispatch.com/news/nz-patients-consider-new-political-party-to-take-on-pharmac 2019-07-31T15:00:01+10:00 https://pharmadispatch.com/news/gilead-launches-2020-fellowship-research-grants 2019-07-31T15:00:01+10:00 https://pharmadispatch.com/news/supply-chain-reform-accounting-change-and-serialisation 2019-08-01T15:00:01+10:00 https://pharmadispatch.com/news/cv-mission-to-back-development-of-medicines-and-therapies 2019-08-01T15:00:01+10:00 https://pharmadispatch.com/news/vertex-commenced-discussions-on-symdeko 2019-08-01T15:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-government-will-be-maintaining-the-existing-criteria 2019-07-31T15:00:01+10:00 https://pharmadispatch.com/news/be-prepared-to-re-argue-principles-like-timely-access 2019-08-02T15:00:01+10:00 https://pharmadispatch.com/news/pbac-rethink-on-hcv-data-collection 2019-08-02T15:00:01+10:00 https://pharmadispatch.com/news/telix-announces-new-collaboration-with-global-biopharma 2019-08-02T15:00:01+10:00 https://pharmadispatch.com/news/companies-welcome-new-listings-headlined-by-new-biosim 2019-08-02T15:00:01+10:00 https://pharmadispatch.com/news/ma-members-to-consider-changes-to-board-appointments 2019-08-05T15:00:01+10:00 https://pharmadispatch.com/news/history-shows-virtually-everything-happens-for-a-reason 2019-08-05T15:00:01+10:00 https://pharmadispatch.com/news/canada-supply-chain-concern-over-importation-proposal 2019-08-05T15:00:01+10:00 https://pharmadispatch.com/news/uk-funds-larger-medicine-stockpile-ahead-of-no-deal-brexit 2019-08-05T15:00:01+10:00 https://pharmadispatch.com/news/are-some-of-the-unresolved-issues-unresolvable 2019-08-06T15:00:01+10:00 https://pharmadispatch.com/news/npsa-look-elsewhere-when-it-comes-to-pbs-spend 2019-08-06T15:00:01+10:00 https://pharmadispatch.com/news/sta-welcomes-approval-of-new-eye-therapy 2019-08-06T15:00:01+10:00 https://pharmadispatch.com/news/new-report-highlights-slow-down-in-uptake-of-hcv-therapies 2019-08-06T15:00:01+10:00 https://pharmadispatch.com/news/how-we-evaluate-might-be-the-easiest-question-to-answer 2019-08-07T15:00:01+10:00 https://pharmadispatch.com/news/what-happens-when-the-government-is-paying-for-less-failure 2019-08-07T15:00:01+10:00 https://pharmadispatch.com/news/what-is-the-spending-starting-point-for-7cpa 2019-08-07T15:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-on-the-lookout-for-nsw-manager 2019-08-07T15:00:01+10:00 https://pharmadispatch.com/news/opthea-in-trading-halt-ahead-of-trial-update 2019-08-07T15:00:01+10:00 https://pharmadispatch.com/news/public-funding-claim-reveals-a-stunning-naivety 2019-08-08T15:00:01+10:00 https://pharmadispatch.com/news/new-global-headquarters-for-csl 2019-08-07T20:00:01+10:00 https://pharmadispatch.com/news/accepting-the-facilitated-pathway-might-be-about-minimising-risk 2019-08-08T15:00:01+10:00 https://pharmadispatch.com/news/victoria-looks-to-grow-biomedical-precinct 2019-08-08T15:00:01+10:00 https://pharmadispatch.com/news/pharmac-bends-on-key-cancer-therapy 2019-08-08T15:00:01+10:00 https://pharmadispatch.com/news/new-report-confirms-record-number-of-biomarkers-for-cancer 2019-08-09T15:00:01+10:00 https://pharmadispatch.com/news/recognition-for-gilead-on-lgbti-inclusion 2019-08-09T15:00:01+10:00 https://pharmadispatch.com/news/latest-merger-could-reverberate-through-sector 2019-08-09T00:33:01+10:00 https://pharmadispatch.com/news/bayer-backs-two-young-cv-researchers 2019-08-12T15:00:01+10:00 https://pharmadispatch.com/news/cancer-survey-highlights-patient-perspective 2019-08-09T15:00:01+10:00 https://pharmadispatch.com/news/abbvie-and-novartis-make-top-ten-innovation-list 2019-08-09T15:00:01+10:00 https://pharmadispatch.com/news/allergan-partners-in-gene-therapy 2019-08-12T15:00:01+10:00 https://pharmadispatch.com/news/the-opportunity-of-new-funding-pathways 2019-08-12T15:00:01+10:00 https://pharmadispatch.com/news/research-based-companies-argue-discrimination-on-submission-date 2019-08-12T15:00:01+10:00 https://pharmadispatch.com/news/recommend-this-recommend-all 2019-08-12T15:00:01+10:00 https://pharmadispatch.com/news/new-report-highlights-access-shortfalls 2019-08-13T15:00:01+10:00 https://pharmadispatch.com/news/how-do-you-make-evidence-based-decisions-when-there-is-no-eviden 2019-08-13T15:00:01+10:00 https://pharmadispatch.com/news/boehringer-ingelheim-and-eli-lilly-announced-expanded-research-g 2019-08-13T15:00:01+10:00 https://pharmadispatch.com/news/nationwide-network-of-car-t-treatment-centres 2019-08-13T03:00:01+10:00 https://pharmadispatch.com/news/history-says-be-alert-but-not-alarmed 2019-08-14T15:00:01+10:00 https://pharmadispatch.com/news/two-gene-therapy-events-per-week 2019-08-14T15:00:01+10:00 https://pharmadispatch.com/news/new-policy-focus-for-pharmacy-guild 2019-08-14T15:00:01+10:00 https://pharmadispatch.com/news/new-collaboration-for-alnylams-rnai-but-still-no-australia 2019-08-14T15:00:01+10:00 https://pharmadispatch.com/news/csl-reports-higher-revenue-and-profit 2019-08-14T18:49:01+10:00 https://pharmadispatch.com/news/new-australian-report-highlights-shift-away-from-one-size-fits-a 2019-08-15T15:00:01+10:00 https://pharmadispatch.com/news/sydney-based-noxoxpharm-looking-to-make-cold-tumours-hot 2019-08-15T15:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-decision-making-a-process-an-independent-locked-box 2019-08-14T22:38:01+10:00 https://pharmadispatch.com/news/bms-launches-new-video-explaining-immuno-oncology 2019-08-15T15:00:01+10:00 https://pharmadispatch.com/news/ma-stalwart-confirms-retirement-after-30-years 2019-08-15T15:00:01+10:00 https://pharmadispatch.com/news/what-happens-when-for-incremental-benefits 2019-08-16T14:00:01+10:00 https://pharmadispatch.com/news/the-word-innovation-has-been-overused-but-this-is-seriously-game 2019-08-16T14:00:01+10:00 https://pharmadispatch.com/news/roche-confirms-new-tecentriq-indication-ahead-of-potential-reimb 2019-08-16T14:00:01+10:00 https://pharmadispatch.com/news/nz-patients-lodge-another-nine-petitions 2019-08-16T14:00:01+10:00 https://pharmadispatch.com/news/page-co-founders-on-its-creation-achievements-and-personal-refle 2019-08-19T15:00:01+10:00 https://pharmadispatch.com/news/biopharmadispatch-launches-podcasts 2019-08-19T15:00:01+10:00 https://pharmadispatch.com/news/sanofi-hosts-students-for-national-science-week 2019-08-19T15:00:01+10:00 https://pharmadispatch.com/news/industry-secures-extension-after-intervention 2019-08-19T15:00:01+10:00 https://pharmadispatch.com/news/pm-look-beyond-corporate-interests-on-policy 2019-08-20T15:00:01+10:00 https://pharmadispatch.com/news/is-the-policy-implementation-split-really-that-simple 2019-08-20T15:00:01+10:00 https://pharmadispatch.com/news/sanofi-partners-on-new-insulin-service 2019-08-20T15:00:01+10:00 https://pharmadispatch.com/news/fda-rejects-sareptas-second-rna-therapy 2019-08-21T15:00:01+10:00 https://pharmadispatch.com/news/page-co-founders-on-opening-the-door-to-discussions-on-diversity 2019-08-21T15:00:01+10:00 https://pharmadispatch.com/news/biogen-backs-new-learning-resource 2019-08-21T15:00:01+10:00 https://pharmadispatch.com/news/inclinic-sigma-launches-australias-first-telehealth-services-in- 2019-08-21T15:00:01+10:00 https://pharmadispatch.com/news/bayer-agrees-to-sell-animal-health-business 2019-08-21T15:00:01+10:00 https://pharmadispatch.com/news/bayer-makes-another-move-into-cell-therapy 2019-08-22T15:00:01+10:00 https://pharmadispatch.com/news/government-could-come-for-more-given-savings-shortfall 2019-08-22T15:00:01+10:00 https://pharmadispatch.com/news/patients-might-be-hoping-their-medicine-belongs-to-a-large-compa 2019-08-22T15:00:01+10:00 https://pharmadispatch.com/news/pfizer-to-invest-us500m-in-gene-therapy-manufacturing 2019-08-22T15:00:01+10:00 https://pharmadispatch.com/news/the-post-rebate-era-has-started-with-or-without-supply-chain-ref 2019-08-23T15:00:01+10:00 https://pharmadispatch.com/news/is-there-even-a-plan-for-emerging-therapies-in-australia 2019-08-23T15:00:01+10:00 https://pharmadispatch.com/news/federal-government-still-finalising-car-t-agreement-with-peter-m 2019-08-23T15:00:01+10:00 https://pharmadispatch.com/news/ebos-looking-to-the-next-wave-of-growth 2019-08-23T15:00:01+10:00 https://pharmadispatch.com/news/roche-launches-new-employee-value-proposition 2019-08-26T15:00:01+10:00 https://pharmadispatch.com/news/clinical-need-and-financial-opportunity-cost 2019-08-26T15:00:01+10:00 https://pharmadispatch.com/news/john-alexander-joins-students-for-amgen-biotech-experience 2019-08-26T15:00:01+10:00 https://pharmadispatch.com/news/minor-changes-and-pricing-variations-dominate-july-outcomes 2019-08-26T15:00:01+10:00 https://pharmadispatch.com/news/camurus-welcomes-buvidal-listing 2019-08-26T15:00:01+10:00 https://pharmadispatch.com/news/new-report-highlights-extent-of-cancer-treatment 2019-08-27T15:00:01+10:00 https://pharmadispatch.com/news/is-it-time-to-accept-the-reality-on-the-pbs 2019-08-27T15:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-considers-board-term-limit 2019-08-27T15:00:01+10:00 https://pharmadispatch.com/news/pharmadispatch-2020-save-the-date 2019-08-27T15:00:01+10:00 https://pharmadispatch.com/news/possible-australian-redux-for-celgenes-otezla 2019-08-27T15:00:01+10:00 https://pharmadispatch.com/news/is-this-the-worst-idea-ever-proposed-for-the-pbs 2019-08-27T20:00:01+10:00 https://pharmadispatch.com/news/does-money-talk-when-it-comes-to-the-clinical-need-barrier 2019-08-28T15:00:01+10:00 https://pharmadispatch.com/news/global-hta-leader-to-step-down 2019-08-28T15:00:01+10:00 https://pharmadispatch.com/news/industry-recognised-in-2019-great-places-to-work-study 2019-08-28T15:00:01+10:00 https://pharmadispatch.com/news/page-better-than-most-but-work-to-be-done-on-pay-gap 2019-08-28T15:00:01+10:00 https://pharmadispatch.com/news/dispensing-doctors-would-corrupt-the-relationship-with-industry 2019-08-28T15:00:01+10:00 https://pharmadispatch.com/news/could-companies-consider-what-was-once-inconceivable 2019-08-29T15:00:01+10:00 https://pharmadispatch.com/news/another-call-for-urgent-action-on-pharmac 2019-08-29T15:00:01+10:00 https://pharmadispatch.com/news/what-hope-for-novel-combination-therapies 2019-08-29T15:00:01+10:00 https://pharmadispatch.com/news/new-and-old-for-novembers-pbac-meeting 2019-08-29T15:00:01+10:00 https://pharmadispatch.com/news/csl-signs-agreement-with-gene-therapy-company-mustang-bio 2019-08-30T14:00:01+10:00 https://pharmadispatch.com/news/new-report-measures-the-process-not-time-to-access 2019-08-30T14:00:01+10:00 https://pharmadispatch.com/news/ma-launches-centralised-reporting-system 2019-08-30T14:00:01+10:00 https://pharmadispatch.com/news/janssen-extends-collaboration-with-melbourne-based-research-inst 2019-08-30T14:00:01+10:00 https://pharmadispatch.com/news/departmental-gift-disclosure-redacts-key-information 2019-09-02T05:00:01+10:00 https://pharmadispatch.com/news/a-laughable-irony-or-serious-and-rank-hypocrisy 2019-09-02T05:00:01+10:00 https://pharmadispatch.com/news/companies-welcome-pbs-update-as-minister-announces-flu-vax-exten 2019-09-02T05:00:01+10:00 https://pharmadispatch.com/news/government-to-create-national-taskforce-on-blood-cancer 2019-09-02T05:00:01+10:00 https://pharmadispatch.com/news/plenty-of-options-if-the-government-moves-to-fill-shortfall 2019-09-02T05:00:01+10:00 https://pharmadispatch.com/news/mixed-response-to-nz-cancer-action-plan 2019-09-03T13:00:01+10:00 https://pharmadispatch.com/news/new-excitement-over-vaccines-that-will-redefine-what-they-mean 2019-09-03T13:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-considering-working-group-for-new-technologies 2019-09-03T13:00:01+10:00 https://pharmadispatch.com/news/ma-foi-act-provides-useful-guidance-on-managing-redactions 2019-09-03T13:00:01+10:00 https://pharmadispatch.com/news/why-are-some-immunotherapies-vaccines-and-others-are-not 2019-09-04T14:00:01+10:00 https://pharmadispatch.com/news/a-touch-of-mission-control-for-novartis-clinical-trials 2019-09-04T14:00:01+10:00 https://pharmadispatch.com/news/pharmac-bends-again-on-cancer-medicines 2019-09-04T14:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-calls-for-support-on-rd-tax-research 2019-09-04T14:00:01+10:00 https://pharmadispatch.com/news/astrazeneca-looking-to-first-line-treatment-for-asthma-therapy 2019-09-05T14:00:01+10:00 https://pharmadispatch.com/news/the-big-one-is-crispr-editing 2019-09-05T14:00:01+10:00 https://pharmadispatch.com/news/the-go-big-or-go-home-challenge 2019-09-05T14:00:01+10:00 https://pharmadispatch.com/news/companies-informed-of-outcome-as-process-moves-towards-foundatio 2019-09-05T14:00:01+10:00 https://pharmadispatch.com/news/coming-next-podcast-with-roches-stuart-knight 2019-09-05T14:00:01+10:00 https://pharmadispatch.com/news/roche-gm-stuart-knight-speaks-with-biopharmadispatch 2019-09-06T14:00:01+10:00 https://pharmadispatch.com/news/sigma-focused-on-transformation 2019-09-06T14:00:01+10:00 https://pharmadispatch.com/news/l-and-gene-to-grow-but-not-dominate-yet 2019-09-06T14:00:01+10:00 https://pharmadispatch.com/news/vertex-expands-in-gene-editing-and-stem-cell-therapy 2019-09-06T14:00:01+10:00 https://pharmadispatch.com/news/mundipharma-backing-new-scholarship 2019-09-06T14:00:01+10:00 https://pharmadispatch.com/news/msd-wins-two-categories-and-shares-another-with-abbvie 2019-09-09T13:00:01+10:00 https://pharmadispatch.com/news/leah-goodman-the-system-is-in-trouble 2019-09-09T13:00:01+10:00 https://pharmadispatch.com/news/dr-emanuele-ostuni-on-building-a-cell-and-gene-organisation 2019-09-09T13:00:01+10:00 https://pharmadispatch.com/news/opthea-updates-on-new-trial-analysis 2019-09-09T13:00:01+10:00 https://pharmadispatch.com/news/alnylam-updates-on-cholesterol-lowering-rna-based-medicine 2019-09-10T15:00:01+10:00 https://pharmadispatch.com/news/pharmac-forcing-more-kiwis-overseas-for-treatment 2019-09-09T15:00:01+10:00 https://pharmadispatch.com/news/az-reports-data-from-immunotherapy-trial 2019-09-10T15:00:01+10:00 https://pharmadispatch.com/news/productivity-commission-chair-calls-for-change 2019-09-10T15:00:01+10:00 https://pharmadispatch.com/news/another-step-towards-novel-combination-therapy-for-multiple-myel 2019-09-11T15:00:01+10:00 https://pharmadispatch.com/news/mesoblast-partners-with-grnenthal-on-cell-therapy 2019-09-11T15:00:01+10:00 https://pharmadispatch.com/news/companies-facing-some-surprises-with-new-pathways-and-fees 2019-09-11T03:32:01+10:00 https://pharmadispatch.com/news/pharmacy-gathers-for-annual-parliamentary-dinner 2019-09-11T15:00:01+10:00 https://pharmadispatch.com/news/astrazenecascraps-direct-distribution 2019-09-12T15:00:01+10:00 https://pharmadispatch.com/news/pulling-every-lever-except-the-one-supposed-to-work 2019-09-12T15:00:01+10:00 https://pharmadispatch.com/news/australian-companies-make-innovation-list 2019-09-12T15:00:01+10:00 https://pharmadispatch.com/news/new-sydney-office-for-global-search-specialist 2019-09-12T15:00:01+10:00 https://pharmadispatch.com/news/biotech-leaders-in-canberra-to-promote-rd-investment 2019-09-13T13:00:01+10:00 https://pharmadispatch.com/news/industry-hackles-over-compassionate-access-pressure 2019-09-13T13:00:01+10:00 https://pharmadispatch.com/news/mundipharma-could-be-sold-as-part-of-us-opioid-settlement 2019-09-13T13:00:01+10:00 https://pharmadispatch.com/news/icon-acquires-hong-kong-oncology-group 2019-09-13T13:00:01+10:00 https://pharmadispatch.com/news/nominations-open-against-a-backdrop-of-change 2019-09-16T15:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-moves-to-broaden-product-focus 2019-09-16T15:00:01+10:00 https://pharmadispatch.com/news/venture-capital-leaders-warns-against-impact-of-government-claim 2019-09-16T15:00:01+10:00 https://pharmadispatch.com/news/industry-watching-for-final-budget-outcome 2019-09-16T15:00:01+10:00 https://pharmadispatch.com/news/boehringer-ingelheim-funded-grant-for-stroke-ai-project 2019-09-16T15:00:01+10:00 https://pharmadispatch.com/news/bms-launches-employee-experience-initiative 2019-09-17T15:00:01+10:00 https://pharmadispatch.com/news/chris-bowen-targeting-government-strength-on-pbs 2019-09-17T15:00:01+10:00 https://pharmadispatch.com/news/lundbeck-acquires-us-biologics-company 2019-09-17T15:00:01+10:00 https://pharmadispatch.com/news/kazia-therapeutics-wins-trans-tasman-innovation-award 2019-09-17T15:00:01+10:00 https://pharmadispatch.com/news/lauren-carey-review-a-great-opportunity-to-shape-future-landscap 2019-09-18T15:00:01+10:00 https://pharmadispatch.com/news/consortium-to-target-utilisation-of-bdmards 2019-09-18T15:00:01+10:00 https://pharmadispatch.com/news/sanofi-and-abbott-working-on-technology-convergence 2019-09-18T15:00:01+10:00 https://pharmadispatch.com/news/innovation-and-ip-the-focus-for-us-delegation 2019-09-18T15:00:01+10:00 https://pharmadispatch.com/news/tga-teams-up-with-fda-and-health-canada-on-oncology-approval 2019-09-18T15:00:01+10:00 https://pharmadispatch.com/news/new-study-links-gene-mutation-to-disease 2019-09-19T15:00:01+10:00 https://pharmadispatch.com/news/new-deal-with-australian-cell-therapy-company 2019-09-19T15:00:01+10:00 https://pharmadispatch.com/news/patrick-kilbride-on-restoring-the-global-consensus 2019-09-19T15:00:01+10:00 https://pharmadispatch.com/news/the-industry-preparing-for-no-deal-brexit 2019-09-19T15:00:01+10:00 https://pharmadispatch.com/news/james-mcdonnell-industry-on-the-cusp-of-something-quite-extraord 2019-09-20T15:00:01+10:00 https://pharmadispatch.com/news/pharmaceutical-spend-down-slightly-on-bugdet-forecast 2019-09-19T20:43:01+10:00 https://pharmadispatch.com/news/inova-looking-for-local-innovators 2019-09-20T15:00:01+10:00 https://pharmadispatch.com/news/not-a-great-combination-for-the-sector 2019-09-20T15:00:01+10:00 https://pharmadispatch.com/news/novartis-provides-updated-data-on-gene-therapy 2019-09-20T15:00:01+10:00 https://pharmadispatch.com/news/the-search-for-the-worlds-best-emerging-science 2019-09-22T15:00:01+10:00 https://pharmadispatch.com/news/who-are-these-agreements-really-meant-to-serve 2019-09-23T15:00:01+10:00 https://pharmadispatch.com/news/analysing-the-pbs-may-be-about-to-get-easier 2019-09-23T15:00:01+10:00 https://pharmadispatch.com/news/overcoming-zombies-and-finding-the-new-famous-australians 2019-09-23T15:00:01+10:00 https://pharmadispatch.com/news/savings-shortfall-behind-growth-wedge 2019-09-24T15:00:01+10:00 https://pharmadispatch.com/news/former-ma-chair-to-lead-medicinal-cannabis-company 2019-09-24T15:00:01+10:00 https://pharmadispatch.com/news/pfizer-inks-new-agreement-with-theuniversity-of-melbourne 2019-09-24T15:00:01+10:00 https://pharmadispatch.com/news/immutep-secures-milestone-payment-from-gsk 2019-09-24T15:00:01+10:00 https://pharmadispatch.com/news/growth-demand-will-not-be-for-just-any-growth 2019-09-25T15:00:01+10:00 https://pharmadispatch.com/news/the-new-paig-releases-2020-21-prospectus 2019-09-25T15:00:01+10:00 https://pharmadispatch.com/news/bluebird-bio-updates-on-latest-gene-therapy 2019-09-25T15:00:01+10:00 https://pharmadispatch.com/news/industry-slams-new-us-pricing-proposal 2019-09-25T15:00:01+10:00 https://pharmadispatch.com/news/astrazeneca-welcomes-new-lynparza-approval 2019-09-26T15:00:01+10:00 https://pharmadispatch.com/news/new-report-confirms-australian-love-for-unsubsidised-medicines 2019-09-26T15:00:01+10:00 https://pharmadispatch.com/news/csl-and-government-backed-fund-back-new-university-spinout 2019-09-26T15:00:01+10:00 https://pharmadispatch.com/news/industry-leader-opts-to-step-down 2019-09-26T01:25:01+10:00 https://pharmadispatch.com/news/csl-exits-medicines-australia 2019-09-26T15:00:01+10:00 https://pharmadispatch.com/news/no-doubting-the-wes-cook-legacy 2019-09-26T15:00:01+10:00 https://pharmadispatch.com/news/bms-neil-macgregor-a-review-is-not-about-fixing-yesterdays-probl 2019-09-27T15:00:01+10:00 https://pharmadispatch.com/news/uk-plan-to-wreck-the-countrys-medical-rd-effort 2019-09-27T15:00:01+10:00 https://pharmadispatch.com/news/gsk-launches-local-spectrum-group 2019-09-27T15:00:01+10:00 https://pharmadispatch.com/news/juno-pharmaceuticals-to-market-key-biosimilars 2019-09-27T15:00:01+10:00 https://pharmadispatch.com/news/new-report-highlights-vagaries-of-pbs-spend 2019-09-27T15:00:01+10:00 https://pharmadispatch.com/news/nominations-set-to-close-for-ma-board 2019-09-30T15:00:01+10:00 https://pharmadispatch.com/news/experienced-industry-executive-joins-gbma-board 2019-09-30T15:00:01+10:00 https://pharmadispatch.com/news/pbac-decides-against-single-nsclc-listing-for-now 2019-09-30T15:00:01+10:00 https://pharmadispatch.com/news/grants-to-support-new-translation-projects 2019-09-30T15:00:01+10:00 https://pharmadispatch.com/news/reports-of-seizures-after-pharmac-ignores-advice-and-forces-swit 2019-10-01T15:00:01+10:00 https://pharmadispatch.com/news/key-lung-cancer-listing-leads-october-announcement 2019-09-30T22:58:01+10:00 https://pharmadispatch.com/news/msds-michael-azrak-we-cannot-secure-change-alone 2019-10-01T15:00:01+10:00 https://pharmadispatch.com/news/a-change-of-language-that-reflects-the-reality 2019-10-01T15:00:01+10:00 https://pharmadispatch.com/news/ma-member-companies-get-ready-to-vote 2019-10-01T15:00:01+10:00 https://pharmadispatch.com/news/new-healthcare-leadership-for-weber-shandwick 2019-10-02T15:00:01+10:00 https://pharmadispatch.com/news/something-the-sector-should-be-watching-closely 2019-10-02T15:00:01+10:00 https://pharmadispatch.com/news/a-big-week-of-biosimilars 2019-10-02T15:00:01+10:00 https://pharmadispatch.com/news/the-important-part-may-be-the-bit-you-cannot-see 2019-10-03T15:00:01+10:00 https://pharmadispatch.com/news/fdas-project-orbis-head-in-australia 2019-10-03T15:00:01+10:00 https://pharmadispatch.com/news/industry-misses-out-on-stem-cell-advisory-panel 2019-10-03T15:00:01+10:00 https://pharmadispatch.com/news/pbs-savings-fund-other-parts-of-the-health-system 2019-10-03T15:00:01+10:00 https://pharmadispatch.com/news/workshop-considers-how-to-harness-genomics 2019-10-03T15:00:01+10:00 https://pharmadispatch.com/news/biogen-impresses-with-new-spinraza-data 2019-10-04T15:00:01+10:00 https://pharmadispatch.com/news/applicants-swamp-new-clinical-trial-grants-program 2019-10-04T15:00:01+10:00 https://pharmadispatch.com/news/fresenius-kabi-joins-gbma 2019-10-04T15:00:01+10:00 https://pharmadispatch.com/news/a-culture-of-patient-access-must-pervade-decision-making 2019-10-04T15:00:01+10:00 https://pharmadispatch.com/news/broad-listing-rejected-after-companies-stood-firm-on-pd-l1-price 2019-10-07T16:00:01+11:00 https://pharmadispatch.com/news/pbac-and-msd-still-debating-keytruda-pricing 2019-10-07T16:00:01+11:00 https://pharmadispatch.com/news/august-outcomes-confirm-win-for-myeloma-patients 2019-10-07T16:00:01+11:00 https://pharmadispatch.com/news/blow-for-the-psa-with-deputy-ceo-departure 2019-10-08T16:00:01+11:00 https://pharmadispatch.com/news/there-is-something-unusual-about-this-negotiation-so-far 2019-10-08T16:00:01+11:00 https://pharmadispatch.com/news/gene-therapy-company-updates-on-cash-runway 2019-10-08T16:00:01+11:00 https://pharmadispatch.com/news/mixed-response-to-latest-pharmac-decision 2019-10-08T16:00:01+11:00 https://pharmadispatch.com/news/liz-chatwin-our-industry-is-more-than-just-medicines 2019-10-09T16:00:01+11:00 https://pharmadispatch.com/news/the-roi-of-technologically-enhanced-patient-centric-clinical-tri 2019-10-09T16:00:01+11:00 https://pharmadispatch.com/news/no-answer-to-what-seems-a-very-simple-question 2019-10-09T16:00:01+11:00 https://pharmadispatch.com/news/is-this-number-based-on-something-other-than-actual-items 2019-10-10T16:00:01+11:00 https://pharmadispatch.com/news/leadership-appointment-for-gsk-pfizer-joint-venture 2019-10-10T16:00:01+11:00 https://pharmadispatch.com/news/australian-medicinal-cannabis-company-merges-with-us-based-count 2019-10-10T16:00:01+11:00 https://pharmadispatch.com/news/australian-company-surges-on-fda-approval 2019-10-10T16:00:01+11:00 https://pharmadispatch.com/news/cancer-and-malaria-the-focus-of-new-csl-centenary-fellowships 2019-10-11T16:00:01+11:00 https://pharmadispatch.com/news/some-of-these-items-are-numbers-just-numbers 2019-10-11T16:00:01+11:00 https://pharmadispatch.com/news/industry-executive-to-lead-emerging-australian-biopharma-adalta 2019-10-11T16:00:01+11:00 https://pharmadispatch.com/news/return-to-new-zealand-unsafe-for-sma-patient 2019-10-11T16:00:01+11:00 https://pharmadispatch.com/news/sanofis-karen-hood-industry-needs-a-clear-and-specific-plan 2019-10-14T16:00:01+11:00 https://pharmadispatch.com/news/government-backs-new-cell-and-tissue-research-facility 2019-10-14T16:00:01+11:00 https://pharmadispatch.com/news/industry-right-in-the-crosshairs 2019-10-14T16:00:01+11:00 https://pharmadispatch.com/news/industry-prepares-to-gather-in-canberra-for-pharmaus19 2019-10-14T16:00:01+11:00 https://pharmadispatch.com/news/new-cabinet-handbook-brings-forward-budget-process 2019-10-14T16:00:01+11:00 https://pharmadispatch.com/news/lundbeck-and-otsuka-on-the-bridge-for-mental-health 2019-10-14T16:00:01+11:00 https://pharmadispatch.com/news/what-next-for-tumour-agnostic-therapies 2019-10-15T16:00:01+11:00 https://pharmadispatch.com/news/csl-marks-25-years-since-privatisation 2019-10-15T16:00:01+11:00 https://pharmadispatch.com/news/are-new-items-the-same-as-new-listings 2019-10-14T22:26:01+11:00 https://pharmadispatch.com/news/new-licensing-deal-for-specialised-therapeutics 2019-10-15T16:00:01+11:00 https://pharmadispatch.com/news/bowen-backed-review-knowing-it-would-probably-mean-more-for-pbs 2019-10-15T16:00:01+11:00 https://pharmadispatch.com/news/frank-lichtenberg-70-is-the-new-60-and-80-the-new-70 2019-10-15T16:00:01+11:00 https://pharmadispatch.com/news/hunt-we-have-listed-more-and-cut-listing-times 2019-10-15T22:03:01+11:00 https://pharmadispatch.com/news/department-of-health-ask-the-ministers-office 2019-10-16T16:00:01+11:00 https://pharmadispatch.com/news/government-not-really-telling-the-truth-on-pbs 2019-10-16T16:00:01+11:00 https://pharmadispatch.com/news/psa-confirms-appointment-of-new-ceo 2019-10-16T16:00:01+11:00 https://pharmadispatch.com/news/pbac-chair-shares-his-thoughts-on-review 2019-10-16T16:00:01+11:00 https://pharmadispatch.com/news/pricing-proposal-will-destroy-the-industry-and-halve-drug-approv 2019-10-17T16:00:01+11:00 https://pharmadispatch.com/news/us-proposal-a-game-over-moment-for-australia 2019-10-17T16:00:01+11:00 https://pharmadispatch.com/news/how-the-federal-government-gets-to-2200-medicines 2019-10-17T16:00:01+11:00 https://pharmadispatch.com/news/threshold-legislations-sparks-renewed-pbs-debate 2019-10-17T16:00:01+11:00 https://pharmadispatch.com/news/companies-already-contemplating-the-risk-of-pelosi-plan 2019-10-18T16:00:01+11:00 https://pharmadispatch.com/news/gilead-elimination-in-reach-but-more-work-required 2019-10-18T16:00:01+11:00 https://pharmadispatch.com/news/baby-boom-at-mundipharma-in-response-to-policy-change 2019-10-18T16:00:01+11:00 https://pharmadispatch.com/news/bayer-backs-program-targeting-physical-health-in-rural-australia 2019-10-18T16:00:01+11:00 https://pharmadispatch.com/news/patients-welcome-new-action-plan-for-osteoporosis 2019-10-18T16:00:01+11:00 https://pharmadispatch.com/news/it-was-like-throwing-darts-at-a-dartboard-while-blindfolded 2019-10-21T16:00:01+11:00 https://pharmadispatch.com/news/payments-in-advance-and-a-higher-interest-rate 2019-10-21T16:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-unlikely-to-lose-sleep-over-that-list 2019-10-21T16:00:01+11:00 https://pharmadispatch.com/news/patients-welcome-much-anticipated-cystic-fibrosis-listings 2019-10-21T16:00:01+11:00 https://pharmadispatch.com/news/inova-sets-four-challenges-for-ipitch 2019-10-21T16:00:01+11:00 https://pharmadispatch.com/news/new-gene-therapy-partnership-between-bluebird-bio-and-novo-nordi 2019-10-22T14:00:01+11:00 https://pharmadispatch.com/news/finance-points-to-improved-pbs-costings-accuracy-in-annual-repor 2019-10-22T14:00:01+11:00 https://pharmadispatch.com/news/extension-for-ma-chair-as-members-prepare-for-agm 2019-10-22T14:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-nine-days-from-agreement-to-listing 2019-10-22T14:00:01+11:00 https://pharmadispatch.com/news/department-of-human-services-reports-flat-pbs-spend 2019-10-23T16:00:01+11:00 https://pharmadispatch.com/news/the-pbs-hit-by-policy-pincer-movement 2019-10-23T16:00:01+11:00 https://pharmadispatch.com/news/estimates-today-but-still-waiting-on-annual-report 2019-10-23T16:00:01+11:00 https://pharmadispatch.com/news/biogen-resurrects-alzheimers-therapy 2019-10-23T16:00:01+11:00 https://pharmadispatch.com/news/pharmac-no-spinraza-because-of-fixed-budget 2019-10-24T16:00:01+11:00 https://pharmadispatch.com/news/annual-report-confirms-growth-and-over-2bn-in-rebates 2019-10-25T02:00:01+11:00 https://pharmadispatch.com/news/novartis-disappointed-as-msac-cites-uncertainty-and-price-in-car 2019-10-24T16:00:01+11:00 https://pharmadispatch.com/news/bms-reports-positive-data-for-opdivo-in-first-line-lung-cancer 2019-10-24T16:00:01+11:00 https://pharmadispatch.com/news/there-risk-of-a-policy-response-to-a-political-problem 2019-10-24T16:00:01+11:00 https://pharmadispatch.com/news/finally-an-explanation-on-the-2200-new-and-amended-medicines 2019-10-24T16:00:01+11:00 https://pharmadispatch.com/news/huge-implications-of-a-convenient-politically-driven-shift 2019-10-25T16:00:01+11:00 https://pharmadispatch.com/news/five-new-directors-for-medicines-australia-board 2019-10-25T04:00:01+11:00 https://pharmadispatch.com/news/pharmaxis-progresses-development-of-lox-inhibitor 2019-10-25T16:00:01+11:00 https://pharmadispatch.com/news/bowen-government-loose-with-the-truth-on-pbs 2019-10-25T16:00:01+11:00 https://pharmadispatch.com/news/recognition-for-csls-paul-perreault 2019-10-25T16:00:01+11:00 https://pharmadispatch.com/news/government-considering-recommendations-of-nps-review 2019-10-25T16:00:01+11:00 https://pharmadispatch.com/news/post-market-review-of-smoking-cessation-therapies 2019-10-25T16:00:01+11:00 https://pharmadispatch.com/news/msac-confirms-date-of-car-t-stakeholder-meeting 2019-10-25T16:00:01+11:00 https://pharmadispatch.com/news/registrations-open-for-biopharmadispatch-2020 2019-10-28T16:00:01+11:00 https://pharmadispatch.com/news/it-is-growth-but-it-could-be-a-savings-shortfall 2019-10-27T05:10:01+11:00 https://pharmadispatch.com/news/department-issues-official-explanation-of-the-2200 2019-10-28T16:00:01+11:00 https://pharmadispatch.com/news/pbs-and-pbac-metrics-in-annual-report 2019-10-28T16:00:01+11:00 https://pharmadispatch.com/news/death-blamed-on-pharmac-forced-switch 2019-10-28T16:00:01+11:00 https://pharmadispatch.com/news/melbourne-hosts-2019-bridge-symposium 2019-10-28T16:00:01+11:00 https://pharmadispatch.com/news/listing-conditions-make-novartis-migraine-biologic-a-no-go 2019-10-28T16:00:01+11:00 https://pharmadispatch.com/news/minister-confirms-some-november-listings 2019-10-28T16:00:01+11:00 https://pharmadispatch.com/news/working-towards-the-conditional-resubmission 2019-10-29T12:00:01+11:00 https://pharmadispatch.com/news/pharmaxis-updates-on-us-bronchitol-progress 2019-10-29T12:00:01+11:00 https://pharmadispatch.com/news/the-risk-of-ministerial-overstatement-on-conditions 2019-10-29T12:00:01+11:00 https://pharmadispatch.com/news/not-bullying-but-there-is-a-history-on-migraine 2019-10-29T12:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-inova-australia-and-new-zealand 2019-10-29T12:00:01+11:00 https://pharmadispatch.com/news/focus-on-the-right-science-and-the-resources-follow 2019-10-30T16:00:01+11:00 https://pharmadispatch.com/news/emerging-australian-biotech-secures-20m-investment 2019-10-30T16:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-to-kick-off-2019-national-conference 2019-10-30T16:00:01+11:00 https://pharmadispatch.com/news/positive-lung-cancer-results-for-azs-pd-l1-inhibitor 2019-10-30T16:00:01+11:00 https://pharmadispatch.com/news/new-uq-spin-out-company-to-target-liver-disease 2019-10-30T16:00:01+11:00 https://pharmadispatch.com/news/new-zealands-medicine-wait-list-grows-again 2019-10-31T16:00:01+11:00 https://pharmadispatch.com/news/pharmaxis-progressing-and-considering-partners 2019-10-31T16:00:01+11:00 https://pharmadispatch.com/news/boehringer-ingelheim-looking-to-bring-tumour-agnostic-trials-to- 2019-10-31T16:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-releases-updated-sector-snapshot 2019-10-31T16:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-confirms-board-change-and-new-deputy-chair 2019-10-31T16:00:01+11:00 https://pharmadispatch.com/news/the-government-disregards-pbac-advice-constantly-and-consistentl 2019-11-01T15:00:01+11:00 https://pharmadispatch.com/news/what-was-greg-hunt-even-talking-about 2019-11-01T15:00:01+11:00 https://pharmadispatch.com/news/response-confirms-the-long-held-view-on-conditions 2019-11-01T15:00:01+11:00 https://pharmadispatch.com/news/the-industry-needs-to-test-the-minister-on-this-issue 2019-11-01T15:00:01+11:00 https://pharmadispatch.com/news/it-is-all-about-the-vibe-and-the-dennis-denuto-defence 2019-11-04T16:00:01+11:00 https://pharmadispatch.com/news/time-to-consider-limits-on-pbac-decision-making 2019-11-05T09:00:01+11:00 https://pharmadispatch.com/news/quality-use-of-medicines-the-new-national-health-priority 2019-11-04T16:00:01+11:00 https://pharmadispatch.com/news/annual-report-confirms-nps-funding-reduction 2019-11-04T16:00:01+11:00 https://pharmadispatch.com/news/praise-for-departing-hepatitis-australia-ceo 2019-11-04T16:00:01+11:00 https://pharmadispatch.com/news/pathways-new-biosimilar-uptake-drivers-and-migraine 2019-11-04T16:00:01+11:00 https://pharmadispatch.com/news/the-human-chemistry-can-be-as-important-as-the-actual-chemsitry 2019-11-05T09:00:01+11:00 https://pharmadispatch.com/news/teva-looking-to-pbs-on-migraine-biologic 2019-11-04T16:00:01+11:00 https://pharmadispatch.com/news/us-has-some-advantages-over-australia-on-health 2019-11-05T09:00:01+11:00 https://pharmadispatch.com/news/how-will-this-be-weaponised-under-greg-hunts-successors 2019-11-06T11:35:01+11:00 https://pharmadispatch.com/news/ma-responds-on-pbac-conditionality 2019-11-06T14:00:01+11:00 https://pharmadispatch.com/news/no-pharmacy-merger-at-this-time 2019-11-06T14:00:01+11:00 https://pharmadispatch.com/news/this-is-how-the-deferrals-policy-could-have-been-sustained 2019-11-06T14:00:01+11:00 https://pharmadispatch.com/news/there-is-no-coming-back-from-that-response 2019-11-07T13:00:01+11:00 https://pharmadispatch.com/news/still-no-disclosed-plans-for-alnylam-in-australia 2019-11-07T13:00:01+11:00 https://pharmadispatch.com/news/martin-palin-on-topicality-integration-and-results 2019-11-07T14:00:01+11:00 https://pharmadispatch.com/news/not-a-new-scenario-but-how-would-the-industry-respond-today 2019-11-08T14:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-to-bring-forward-formation-of-nmp-review-working-group 2019-11-08T14:00:01+11:00 https://pharmadispatch.com/news/us-house-expected-to-back-pelosi-plan 2019-11-08T14:00:01+11:00 https://pharmadispatch.com/news/reducing-submission-churn-by-getting-rid-of-resubmissions 2019-11-11T14:00:01+11:00 https://pharmadispatch.com/news/us-price-reform-stalls-on-key-differences 2019-11-11T14:00:01+11:00 https://pharmadispatch.com/news/bridge-program-announces-2019-pitch-winners 2019-11-11T14:00:01+11:00 https://pharmadispatch.com/news/new-treatment-holds-cv-hope-for-ckd-patients 2019-11-11T14:00:01+11:00 https://pharmadispatch.com/news/exclusive-key-week-for-7cpa-negotiations 2019-11-12T16:30:01+11:00 https://pharmadispatch.com/news/bowen-maintains-pressure-on-flash-monitors 2019-11-12T16:30:01+11:00 https://pharmadispatch.com/news/an-emerging-alignment-of-historic-significance 2019-11-12T16:30:01+11:00 https://pharmadispatch.com/news/novartis-welcomes-tga-approval-ahead-of-pbac-outcome 2019-11-12T16:30:01+11:00 https://pharmadispatch.com/news/roche-backs-lung-health-advocacy-project 2019-11-12T16:30:01+11:00 https://pharmadispatch.com/news/official-opening-of-new-merck-headquarters 2019-11-13T16:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-releases-update-on-local-regenerative-medicine-sector 2019-11-13T16:00:01+11:00 https://pharmadispatch.com/news/department-confirms-emergency-supply-arrangements-for-bushfire-a 2019-11-13T16:00:01+11:00 https://pharmadispatch.com/news/mark-glover-the-tech-opportunity-for-clinical-trials 2019-11-13T16:00:01+11:00 https://pharmadispatch.com/news/take-a-tour-of-mercks-new-office 2019-11-13T16:00:01+11:00 https://pharmadispatch.com/news/pharmac-switch-now-blamed-for-three-deaths 2019-11-14T16:00:01+11:00 https://pharmadispatch.com/news/7cpa-deal-unlikely-in-2019 2019-11-14T16:00:01+11:00 https://pharmadispatch.com/news/new-reports-highlights-system-challenge-for-alzheimers-treatment 2019-11-14T16:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-could-up-the-ante-with-speculated-appointment 2019-11-15T16:00:01+11:00 https://pharmadispatch.com/news/malaria-researcher-wins-gsk-award-for-research-excellence 2019-11-15T16:00:01+11:00 https://pharmadispatch.com/news/australian-company-doses-first-patient-in-tumour-agnostic-study 2019-11-15T16:00:01+11:00 https://pharmadispatch.com/news/stakeholders-leave-meeting-none-the-wider-of-negotiation-progres 2019-11-15T16:00:01+11:00 https://pharmadispatch.com/news/this-system-is-about-rationing-not-valuing 2019-11-18T16:00:01+11:00 https://pharmadispatch.com/news/pharmac-shifts-following-reports-of-another-death 2019-11-18T16:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-announces-funding-for-research-into-rare-cancers-and-d 2019-11-18T16:00:01+11:00 https://pharmadispatch.com/news/new-documents-confirm-focus-on-price-and-cost 2019-11-18T16:00:01+11:00 https://pharmadispatch.com/news/experts-gather-in-sydney-for-meeting-on-value 2019-11-18T16:00:01+11:00 https://pharmadispatch.com/news/research-reveals-no-link-between-statins-and-memory-loss 2019-11-19T16:00:01+11:00 https://pharmadispatch.com/news/rather-than-tinkering-the-push-should-be-to-start-again 2019-11-19T16:00:01+11:00 https://pharmadispatch.com/news/more-criticism-of-pharmac-has-actor-passes-away 2019-11-19T16:00:01+11:00 https://pharmadispatch.com/news/another-confirmed-industry-leader-for-biopharmadispatch-2020 2019-11-19T16:00:01+11:00 https://pharmadispatch.com/news/industry-better-than-most-but-more-work-required-on-gender-pay-g 2019-11-19T16:00:01+11:00 https://pharmadispatch.com/news/minister-doubles-down-on-pharmacy-tribunal 2019-11-20T16:00:01+11:00 https://pharmadispatch.com/news/december-extensions-for-two-cancer-medicines 2019-11-20T16:00:01+11:00 https://pharmadispatch.com/news/companies-clinicians-and-patients-welcome-cancer-listings 2019-11-20T16:00:01+11:00 https://pharmadispatch.com/news/bms-celgene-merger-set-to-close 2019-11-20T16:00:01+11:00 https://pharmadispatch.com/news/npsa-commitment-to-australias-critical-infrastructure-for-health 2019-11-21T16:00:01+11:00 https://pharmadispatch.com/news/wholesaler-move-to-go-it-alone-is-just-onekey-difference 2019-11-21T16:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-frustrated-over-refusal-to-treat-with-car-t 2019-11-21T16:00:01+11:00 https://pharmadispatch.com/news/australian-company-noxopharm-updates-on-pipeline 2019-11-21T16:00:01+11:00 https://pharmadispatch.com/news/the-zombie-reform-that-is-still-meant-to-happen 2019-11-22T16:00:01+11:00 https://pharmadispatch.com/news/novo-nordisk-partners-with-un-on-childhood-obesity 2019-11-22T16:00:01+11:00 https://pharmadispatch.com/news/60-day-dispensing-means-hundreds-of-new-listings 2019-11-22T16:00:01+11:00 https://pharmadispatch.com/news/sustainability-recognition-for-amgen-at-national-awards 2019-11-22T16:00:01+11:00 https://pharmadispatch.com/news/british-labour-would-create-new-drug-company 2019-11-25T16:00:01+11:00 https://pharmadispatch.com/news/more-pressure-on-pharmac-with-call-for-ministerial-inquiry 2019-11-25T16:00:01+11:00 https://pharmadispatch.com/news/vertex-study-demonstrates-potential-power-of-gene-editing 2019-11-25T16:00:01+11:00 https://pharmadispatch.com/news/challenge-the-cult-of-hta-rather-than-extending-it-reach 2019-11-25T16:00:01+11:00 https://pharmadispatch.com/news/novartis-set-for-us9bn-acquisition 2019-11-25T16:00:01+11:00 https://pharmadispatch.com/news/us-pricing-proposal-will-hit-investment-in-high-risk-areas-of-ur 2019-11-26T16:00:01+11:00 https://pharmadispatch.com/news/sanofi-confirms-private-market-launch-for-biologic 2019-11-26T16:00:01+11:00 https://pharmadispatch.com/news/pharmacy-welcomes-government-response-on-aged-care 2019-11-26T16:00:01+11:00 https://pharmadispatch.com/news/australia-towards-the-bottom-of-drug-price-index 2019-11-26T16:00:01+11:00 https://pharmadispatch.com/news/same-product-same-evidence-different-outcome 2019-11-27T16:00:01+11:00 https://pharmadispatch.com/news/the-mystery-of-the-pbac-discussant 2019-11-27T16:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-to-announce-listing-of-new-hiv-therapy 2019-11-27T16:00:01+11:00 https://pharmadispatch.com/news/ma-analysis-confirms-what-we-have-long-known 2019-11-27T04:22:01+11:00 https://pharmadispatch.com/news/the-search-for-discussant-presentations 2019-11-28T16:00:01+11:00 https://pharmadispatch.com/news/new-study-shows-power-of-ai-in-matching-patients-to-clinical-tri 2019-11-28T16:00:01+11:00 https://pharmadispatch.com/news/new-directors-for-arcs-board 2019-11-28T16:00:01+11:00 https://pharmadispatch.com/news/year-likely-to-end-with-significant-unresolved-issues 2019-11-28T16:00:01+11:00 https://pharmadispatch.com/news/dr-paul-stoffels-the-human-biology-revolution 2019-11-29T15:00:01+11:00 https://pharmadispatch.com/news/consumer-healthcare-products-confirms-new-board 2019-11-29T15:00:01+11:00 https://pharmadispatch.com/news/uk-conservatives-promise-to-expand-cancer-drugs-fund 2019-11-29T15:00:01+11:00 https://pharmadispatch.com/news/companies-investing-to-expand-gene-therapy-manufacturing 2019-11-29T15:00:01+11:00 https://pharmadispatch.com/news/how-do-you-reverse-a-decade-of-under-funding 2019-12-02T15:00:01+11:00 https://pharmadispatch.com/news/past-and-present-industry-leaders-pay-tribute-to-policy-and-advo 2019-12-02T15:00:01+11:00 https://pharmadispatch.com/news/vertex-happy-with-december-symdeko-listing 2019-12-02T15:00:01+11:00 https://pharmadispatch.com/news/nz-all-i-want-for-christmas-is-to-live 2019-12-02T15:00:01+11:00 https://pharmadispatch.com/news/pbac-calls-for-follow-up-review-of-risperidone-change 2019-12-02T15:00:01+11:00 https://pharmadispatch.com/news/dr-frank-stangenberg-haverkamp 2019-12-03T12:00:01+11:00 https://pharmadispatch.com/news/new-business-unit-structure-for-novo-nordisk 2019-12-03T12:00:01+11:00 https://pharmadispatch.com/news/institutions-back-australian-company-with-50m-raise 2019-12-03T12:00:01+11:00 https://pharmadispatch.com/news/noxopharm-updates-on-positive-trial-results 2019-12-03T12:00:01+11:00 https://pharmadispatch.com/news/department-has-just-handed-the-industry-its-argument 2019-12-04T15:00:01+11:00 https://pharmadispatch.com/news/national-medicines-policy-review-taking-shape 2019-12-03T23:53:01+11:00 https://pharmadispatch.com/news/response-reveals-the-reality-of-who-owns-information 2019-12-04T15:00:01+11:00 https://pharmadispatch.com/news/sta-welcomes-singapore-approval-of-breast-cancer-therapy 2019-12-04T02:26:01+11:00 https://pharmadispatch.com/news/new-patient-alliance-calls-for-independent-review-of-hta 2019-12-05T12:00:01+11:00 https://pharmadispatch.com/news/artificial-intelligence-to-feature-biopharmadispatch-2020 2019-12-05T12:00:01+11:00 https://pharmadispatch.com/news/csl-highlights-pipeline-at-investor-briefing 2019-12-05T12:00:01+11:00 https://pharmadispatch.com/news/outcomes-can-only-be-judged-if-decision-making-is-transparent 2019-12-05T12:00:01+11:00 https://pharmadispatch.com/news/gsk-opens-pulse-program-for-applications 2019-12-05T12:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-mundipharma-anz-with-jane-orr-announcing-reti 2019-12-06T12:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-astonished-after-rd-tax-cut-legislation-tabled-on-fin 2019-12-06T12:00:01+11:00 https://pharmadispatch.com/news/gsk-welcomes-new-approvals-for-asthma-biologic 2019-12-06T12:00:01+11:00 https://pharmadispatch.com/news/nz-to-fund-azs-ovarian-cancer-therapy-finally 2019-12-06T12:00:01+11:00 https://pharmadispatch.com/news/current-approach-to-hta-is-the-barrier-to-personalised-medicine- 2019-12-09T16:00:01+11:00 https://pharmadispatch.com/news/david-thomas-matching-the-new-world-to-an-old-system 2019-12-09T16:00:01+11:00 https://pharmadispatch.com/news/foundathis-is-simply-the-way-it-has-to-betion-medicine 2019-12-09T16:00:01+11:00 https://pharmadispatch.com/news/nz-coroner-opens-inquiry-on-forced-switch 2019-12-09T16:00:01+11:00 https://pharmadispatch.com/news/invites-to-medicines-policy-review-working-group 2019-12-10T16:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-cuts-threaten-business-sustainability 2019-12-10T16:00:01+11:00 https://pharmadispatch.com/news/new-report-says-pelosi-plan-would-reduce-us-life-expectancy 2019-12-10T16:00:01+11:00 https://pharmadispatch.com/news/sanofi-acquires-synthorx-ahead-of-strategy-update 2019-12-10T16:00:01+11:00 https://pharmadispatch.com/news/msd-announces-us27bn-acquisition-of-arqule 2019-12-11T15:00:01+11:00 https://pharmadispatch.com/news/sanofi-narrows-focus-and-scraps-rd-in-heritage-areas 2019-12-11T15:00:01+11:00 https://pharmadispatch.com/news/model-the-behaviour-you-demand-of-others-1 2019-12-11T15:00:01+11:00 https://pharmadispatch.com/news/key-trade-agreement-scraps-pharma-ip-provision 2019-12-12T16:00:01+11:00 https://pharmadispatch.com/news/still-time-to-take-advantage-of-biopharmadispatch-2020-early-reg 2019-12-12T16:00:01+11:00 https://pharmadispatch.com/news/mrff-program-for-issues-identified-by-pbac 2019-12-12T16:00:01+11:00 https://pharmadispatch.com/news/ma-board-reappoints-dr-anna-lavelle 2019-12-12T16:00:01+11:00 https://pharmadispatch.com/news/clinical-trials-competition-across-country-and-companies 2019-12-13T16:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-abbvie-australia 2019-12-12T23:47:01+11:00 https://pharmadispatch.com/news/high-in-fees-low-on-performance-measures 2019-12-13T16:00:01+11:00 https://pharmadispatch.com/news/deborah-monk-recollections-from-apma-to-medicines-australia 2019-12-13T16:00:01+11:00 https://pharmadispatch.com/news/novartis-launches-innovation-prize-with-a-focus-on-ms 2019-12-13T16:00:01+11:00 https://pharmadispatch.com/news/upjohns-gareth-richmond-on-creating-the-standalone-entity 2019-12-16T16:00:01+11:00 https://pharmadispatch.com/news/the-pbac-ending-a-topsy-turvy-decade-as-two-programs 2019-12-16T16:00:01+11:00 https://pharmadispatch.com/news/these-new-lists-are-the-targets 2019-12-16T16:00:01+11:00 https://pharmadispatch.com/news/two-countries-and-two-major-outcomes-for-the-industry 2019-12-16T16:00:01+11:00 https://pharmadispatch.com/news/no-overall-growth-but-there-are-growth-drivers 2019-12-17T16:00:01+11:00 https://pharmadispatch.com/news/budget-update-confirms-how-little-is-spent-on-new-medicines 2019-12-16T21:00:01+11:00 https://pharmadispatch.com/news/budget-update-a-sobering-reality-for-sector 2019-12-17T16:00:01+11:00 https://pharmadispatch.com/news/next-initiative-for-value-savings-measure 2019-12-17T16:00:01+11:00 https://pharmadispatch.com/news/servier-lines-up-for-a-third-year-of-decembeard 2019-12-17T16:00:01+11:00 https://pharmadispatch.com/news/upjohn-returning-to-wholesalers 2019-12-18T02:30:01+11:00 https://pharmadispatch.com/news/pharmac-knew-of-switch-deaths-but-stayed-silent 2019-12-18T16:00:01+11:00 https://pharmadispatch.com/news/antisense-therapeutics-updates-on-dmd-therapy-development 2019-12-18T16:00:01+11:00 https://pharmadispatch.com/news/associations-team-up-for-annual-luncheon 2019-12-18T16:00:01+11:00 https://pharmadispatch.com/news/just-over-one-week-to-take-advantage-of-early-registration 2019-12-18T16:32:01+11:00 https://pharmadispatch.com/news/industry-gathers-to-pay-tribute-to-deborah-monk 2019-12-19T16:00:01+11:00 https://pharmadispatch.com/news/pharmaxis-updates-on-business-plan-after-bi-halts-study 2019-12-18T20:46:01+11:00 https://pharmadispatch.com/news/pfizers-melissa-mcgregor-reappointed-ma-deputy-chair 2019-12-18T21:03:01+11:00 https://pharmadispatch.com/news/cochlears-anthony-bishop-the-impact-of-a-humbling-experience 2019-12-19T16:00:01+11:00 https://pharmadispatch.com/news/another-license-deal-with-specialised-therapeutics 2019-12-19T16:00:01+11:00 https://pharmadispatch.com/news/few-biologics-take-price-disclosure-reductions-in-april 2019-12-19T16:00:01+11:00 https://pharmadispatch.com/news/the-system-is-evidence-based-or-it-is-not 2019-12-23T14:00:01+11:00 https://pharmadispatch.com/news/migraine-patients-still-waiting-and-narrow-tick-for-bexsero 2019-12-23T14:00:01+11:00 https://pharmadispatch.com/news/tga-fines-mundipharma-over-targin-promotion 2019-12-23T14:00:01+11:00